Jonathan Derrick Adachi - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Professor Emeritus, Medicine, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Contact
View All

selected scholarly activity

chapters
- Critical Issues in Osteoporosis Management. 37-50. 2021
- Metabolic Bone Disease in Gastrointestinal Disorders. 240-257. 2019
- Glucocorticoid-induced osteoporosis. 1674-1679. 2015
- Metabolic Bone Disease. 279-304. 2015
- Bone Aging. 11-16. 2011
- Exercise and the Prevention of Bone Fragility. 117-122. 2006
- Corticosteroid-Induced Osteoporosis: A Comprehensive Review. 981-994. 2004
- Postmenopausal Osteoporosis. 183-242. 2003
- Systemic Lupus Erythematosus. 97-140. 2003
conferences
- Associations between Osteosarcopenia and Falls, Fractures, and Frailty in Older Adults: Results From the Canadian Longitudinal Study on Aging (CLSA). Journal of the American Medical Directors Association. 167-176.e6. 2024
- Associations between Social Isolation Index and changes in grip strength, gait speed, bone mineral density (BMD), and self-reported incident fractures among older adults: Results from the Canadian Longitudinal Study on Aging (CLSA). PLoS ONE. 2023
- THE ASSOCIATION BETWEEN SOCIAL ISOLATION AND LONELINESS AND SARCOPENIA AND OSTEOPOROSIS AMONG OLDER ADULTS: RESULTS FROM THE CANADIAN LONGITUDINAL STUDY ON AGING (CLSA). Aging - Clinical and Experimental Research. S52-S53. 2022
- The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids.. Arthritis & Rheumatology. 604-611. 2022
- Safety and Efficacy of Denosumab vs Risedronate in Patients with Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis. Arthritis & Rheumatology. 916-919. 2021
- Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease. Journal of Bone and Mineral Research. 1437-1445. 2020
- Evaluation of the Fracture Liaison Service within the Canadian Healthcare Setting. Journal of Osteoporosis. 2020
- Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moderate Chronic Kidney Disease. Arthritis & Rheumatology. 2019
- Current Factors Associated with Insufficient Vitamin D Status in Patients with Osteoporosis. Arthritis & Rheumatology. 2018
- Greater BMD Gains with Denosumab Vs Risedronate in Glucocorticoid-Treated Subjects: Results from the Final 24-Month Analysis of a Randomized, Double-Blind, Double-Dummy Study. Arthritis & Rheumatology. 2018
- Subgroup Analysis of the Effect of Denosumab Compared with Risedronate on Percentage Change in Lumbar Spine Bone Mineral Density at 24 Months in Glucocorticoid-Treated Individuals. Arthritis & Rheumatology. 2018
- Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting. Journal of Rheumatology. 170-176. 2018
- Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop. Neuromuscular Disorders. 64-76. 2018
- A Whole Genome Association Meta-Analysis Study Identifies Novel Loci Associated with Bone Microarchitecture Assessed by HR-pQCT independent of aBMD.. Journal of Bone and Mineral Research. S72-S72. 2017
- Are grade 1 vertebral fracture, fractures?. Journal of Bone and Mineral Research. S93-S93. 2017
- Associations of Cognitive Dietary Restraint with Changes in Body Mass Index and Bone Mineral Density: A Population-based Cohort Study of Premenopausal Women and Men Aged 25-49 Years from CaMos.. Journal of Bone and Mineral Research. S250-S250. 2017
- Continued Fracture Risk Reduction After 12 Months of Romosozumab Followed by Denosumab Through 36 Months in the Phase 3 FRAME (FRActure study in postmenopausal woMen with ostEoporosis) Extension.. Journal of Bone and Mineral Research. S24-S24. 2017
- Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk among Oral Glucocorticoid Users.. Journal of Bone and Mineral Research. S267-S267. 2017
- Prediction of Incident Fragility Fractures in Women with Peripheral CT Imaging - One Slice is Often Enough: the CaMos Bone Quality Study. Journal of Bone and Mineral Research. S99-S99. 2017
- Predictors of Near-Term Non-Vertebral Fracture in Elderly Women with Osteoporosis, Osteopenia, or a History of Fracture, Based on Data from the Canadian Multicentre Osteoporosis Study (CaMos). Archives of Osteoporosis. S101-S101. 2017
- Transition to re-fracture and mortality in the elderly: An individualized risk assessment tool for fracture and its outcomes from two large population-based prospective cohort studies.. Journal of Bone and Mineral Research. S19-S19. 2017
- A LARGE NUMBER OF FRAIL OLDER ADULTS LIVING IN LONG TERM CARE HOMES ARE AT HIGH RISK FOR HIP FRACTURE. Osteoporosis International. S632-S632. 2017
- CHRONIC INFLAMMATION AND BONE STRUCTURE. THE POTENTIAL PROTECTIVE ROLE OF BIOLOGIC AGENTS IN THE TREATMENT OF CHRONIC ARTHRITIDES. Osteoporosis International. S111-S114. 2017
- CLINICAL FACTORS PREDICTA GREATER INCREASE IN SPINE BONE DENSITY AFTER LACTATION (FACTORS AFFECTING BONE FORMATION AFTER BREASTFEEDING PILOT STUDY [FABB-PILOT]). Osteoporosis International. S233-S234. 2017
- FRACTURE RISK REDUCTION WITH ROMO-SOZUMAB: RESULTS OF A PHASE 3 STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS. Osteoporosis International. S50-S51. 2017
- GLUCOCORTICOID INDUCED OSTEOPOROSIS. Osteoporosis International. S89-S89. 2017
- INTER-RATER RELIABILITY OF DARTFISH MOVEMENT ANALYSIS SOFTWARE FOR MEASURING MAXIMUM FLEXION AND EXTENSION AT THE HIP AND KNEE IN OLDER ADULTS WITH OSTEOPOROSIS AND OSTEOPENIA. Osteoporosis International. S542-S542. 2017
- ROMOSOZUMAB RAPIDLY REDUCES CLINICAL VERTEBRAL FRACTURE INCIDENCE: RESULTS FROM THE FRAME STUDY. Osteoporosis International. S51-S52. 2017
- Anatomical Patterns Suggest the Involvement of Biomechanical Stress in the Pathogenesis of Erosions in Rheumatoid Arthritis. Arthritis & Rheumatology. 2016
- Effect of Denosumab Compared with Risedronate in Glucocorticoid-Treated Individuals: Results from the 12-Month Primary Analysis of a Randomized, Double-Blind, Active-Controlled Study. Arthritis & Rheumatology. 2016
- Fracture Risk Reduction with Romosozumab: Results of a Phase 3 Study in Postmenopausal Women with Osteoporosis. Arthritis & Rheumatology. 2016
- Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy. Arthritis & Rheumatology. 2016
- What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?. Arthritis & Rheumatology. 2016
- Trends in Oral Glucocorticoid Utilization Among Older Adults with Respiratory Disease. Pharmacoepidemiology and Drug Safety. 494-494. 2016
- FRI0221 Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in A Clinical Setting:. Annals of the Rheumatic Diseases. 512.2-512. 2016
- Trends In Oral Glucocorticoid Utilization Among Older Adults With Respiratory Disease. Value in Health. A120-A120. 2016
- GASTROINTESTINAL EVENTS AND ASSOCIATION WITH QUALITY OF LIFE AMONG OSTEOPOROSIS PATIENTS: 12 MONTH OBSERVATIONS FROM THE MUSIC OS EUROPE AND CANADA STUDY. Osteoporosis International. S396-S397. 2016
- GASTROINTESTINAL EVENTS AND ASSOCIATION WITH TREATMENT SATISFACTION AMONG OSTEOPOROTIC PATIENTS: 12 MONTH OBSERVATIONS FROM THE MUSIC OS EUROPE AND CANADA STUDY. Osteoporosis International. S395-S395. 2016
- Knee mechanics interact with body mass index to predict cartilage loss over 2.5 years in people with clinical knee osteoarthritis. Osteoarthritis and Cartilage. S47-S47. 2016
- SUCCESSFUL MUSCULOSKELETAL AGING. Osteoporosis International. S34-S34. 2016
- THE DEVELOPMENT OF A ONE YEAR FRACTURE PREDICTION TOOL FOR ABSOLUTE HIP FRACTURE RISK IN THE FRAIL ELDERLY. Osteoporosis International. S542-S543. 2016
- THICKER AND DENSER CORTICES BUT LESS INTACT TRABECULAE ARE ASSOCIATED WITH ATYPICAL FEMUR FRACTURES: A CROSS-SECTIONAL CASE-COHORT ANALYSIS. Osteoporosis International. S200-S201. 2016
- Calf Muscle Adiposity Is Associated with Impaired Physical Performance in Knee OA. Arthritis & Rheumatology. 2015
- Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis?. Arthritis & Rheumatology. 2015
- Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting. Arthritis & Rheumatology. 2015
- Efficacy of Osteoporosis Pharmacotherapies in Preventing Fractures among Chronic Oral Glucocorticoids Users: A Network Meta-analysis. Pharmacoepidemiology and Drug Safety. 352-353. 2015
- Evolution of subject characteristics in FREEDOM and its extension for up to 8 years. Australasian Journal on Ageing. 64-65. 2015
- MONITORING OF OSTEOPOROSIS TREATMENTS. Osteoporosis International. S65-S66. 2015
- THE ASSOCIATION OF GASTROINTESTINAL EVENTS ON ADHERENCE TO OSTEOPOROSIS TREATMENT AMONG OSTEOPOROTIC WOMEN: RESULTS OF THE MEDICATION USE PATTERNS, TREATMENT SATISFACTION AND INADEQUATE CONTROL OF OSTEOPOROSIS STUDY (MUSIC-OS). Osteoporosis International. S192-S193. 2015
- THE RATE OF SELF-REPORTED GASTROINTESTINAL EVENTS AMONG OSTEOPOROTIC WOMEN: RESULTS OF THE MEDICATION USE PATTERNS, TREATMENT SATISFACTION AND INADEQUATE CONTROL OF OSTEOPOROSIS STUDY (MUSIC-OS). Osteoporosis International. S197-S197. 2015
- WHAT TRIGGERS OSTEOPOROSIS THERAPY IN HIGH RISK RESIDENTS LIVING IN LONG TERM CARE (LTC) HOMES? THE GAINING OPTIMAL OSTEOPOROSIS ASSESSMENTS IN LONG-TERM CARE (GOAL) STUDY. Osteoporosis International. S52-S53. 2015
- Assessing the Validity and Reliability of a Novel MRI Semi-Automated Algorithm for Quantifying Bone Loss in the Hand.. Arthritis & Rheumatology. S515-S515. 2014
- Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-Ray Erosion Detection.. Arthritis & Rheumatology. S628-S629. 2014
- Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years.. Arthritis & Rheumatology. S981-S981. 2014
- How Does Non-Compliance to Prolia® (DENOSUMAB) Impact the Change in Bone Mineral Density (BMD) in Osteoporotic Patients?. Arthritis & Rheumatology. S982-S983. 2014
- Osteoporotic Women at High Risk for Fractures Despite Two Years of Oral Bisphosphonate Therapy: Analysis Using the Canadian Multicentre Osteoporosis Study. Arthritis & Rheumatology. S20-S20. 2014
- The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis. Arthritis & Rheumatology. S692-S692. 2014
- The Relationship of Quadriceps and Hamstrings Intramuscular Fat and Lean Muscle with Power in Women with Knee Osteoarthritis.. Arthritis & Rheumatology. S91-S91. 2014
- SAT0458 How Does Non-Compliance to Prolia ® (DENOSUMAB) Affect the Change in Bone Mineral Density (BMD)?. Annals of the Rheumatic Diseases. 759.2-760. 2014
- 12-MONTH PERSISTENCE WITH DENOSUMAB THERAPY AMONG OSTEOPOROTIC WOMEN IN THE CANADIAN PATIENT-SUPPORT PROGRAM. Osteoporosis International. S221-S221. 2014
- ANTIOSTEOPOROSIS MEDICATION USE REMAINS LOW AFTER FRACTURE BUT IS RELATED TO SELF PERCEIVED FRACTURE RISK: FINDINGS FROM THE GLOW STUDY. Osteoporosis International. S312-S313. 2014
- EFFECT OF TERIPARATIDE ON HEALING OF INCOMPLETE ATYPICAL FEMUR FRACTURES. Osteoporosis International. S129-S129. 2014
- FRACTURE PATTERNS WITH SELECTIVE SEROTONIN RECEPTOR INHIBITOR, PROTON PUMP INHIBITOR AND GLUCOCORTICOIDS USE IN GLOW. Osteoporosis International. S119-S119. 2014
- FURTHER REDUCTION IN NONVERTEBRAL FRACTURE RATE IS OBSERVED FOLLOWING 3 YEARS OF DENOSUMAB TREATMENT: RESULTS WITH UP TO 7 YEARS IN THE FREEDOM EXTENSION. Osteoporosis International. S128-S128. 2014
- HOW WELL DOES SELF-PERCEPTION OF FRACTURE RISK RELATE TO FRACTURE PROBABILITY USING FRAX? FINDINGS FROM THE GLOW STUDY. Osteoporosis International. S320-S321. 2014
- OSTEOPOROSIS THERAPY, BEYOND FRACTURE PREVENTION. Osteoporosis International. S102-S103. 2014
- PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS. Osteoporosis International. S154-S154. 2014
- RECOMMENDATIONS FOR OSTEOPOROSIS MANAGEMENT AND FRACTURE PREVENTION FOR THE FRAIL ELDERLY IN LONG-TERM CARE (LTC). Osteoporosis International. S231-S232. 2014
- RELATIONSHIP OF WEIGHT, HEIGHT, AND BODY MASS INDEX WITH FRACTURE RISK AT DIFFERENT SITES IN POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW). Osteoporosis International. S107-S108. 2014
- Evolution of Subject Characteristics in FREEDOM and its Extension for Up to 8 Years.. Journal of Bone and Mineral Research. S470-S470. 2014
- Further Reduction In Nonvertebral Fracture Rate Is Observed Following 3 Years Of Denosumab Treatment: Results With Up To 7 Years In The Freedom Extension. Arthritis and Rheumatism. S369-S369. 2013
- Osteoporosis Medication Adherence: Reasons For Stopping and Not Starting. Arthritis and Rheumatism. S525-S525. 2013
- Low incidence of fracture maintained with long-term denosumab treatment in women aged >= 75 years with postmenopausal osteoporosis. Australasian Journal on Ageing. 23-23. 2013
- DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO). Osteoporosis International. S45-S46. 2013
- DENOSUMAB REDUCED OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WITH PRIOR FRACTURE: RESULTS FROM FREEDOM. Osteoporosis International. S299-S300. 2013
- EFFECT OF TERIPARATIDE ON FRACTURE HEALING IN PATIENTS WITH NONDISPLACED INCOMPLETE ATYPICAL FEMUR FRACTURES. Osteoporosis International. S42-S43. 2013
- Increasing knee pain is associated with decreasing proportion of quadriceps within the thigh in women in the OAI. Osteoarthritis and Cartilage. S176-S176. 2013
- Increasing physical activity is associated with increasing muscle to intermuscular fat ratio in the thighs of OAI participants. Osteoarthritis and Cartilage. S178-S178. 2013
- Knee power is an important parameter in understanding medial knee joint load in knee OA. Osteoarthritis and Cartilage. S88-S88. 2013
- OSTEOPOROSIS AND OSTEOARTHRITIS: SIMILARITIES AND DIFFERENCES. Osteoporosis International. S73-S73. 2013
- The peak adduction moment and adduction moment impulse at the knee relate to tibial and femoral cartilage morphology. Osteoarthritis and Cartilage. S44-S44. 2013
- Further Reduction in the Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With Up to 7 Years in the FREEDOM Extension. Journal of Bone and Mineral Research. 2013
- Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center. Arthritis and Rheumatism. S839-S839. 2012
- Low Fracture Incidence Is Maintained in Postmenopausal Women >= 75 Years with Osteoporosis with Long-Term Denosumab Treatment.. Arthritis and Rheumatism. S830-S831. 2012
- Relative, Reliability-Adjusted Diagnostic Test Accuracy of Erosion Detection Between Magnetic Resonance Imaging and Radiography in Rheumatoid Arthritis. Arthritis and Rheumatism. S888-S888. 2012
- Reliability of the Early Erosions in Rheumatoid Arthritis Software When Quantifying Bone Loss.. Arthritis and Rheumatism. S441-S441. 2012
- Systematic Review of the Association Between Magnetic Resonance Imaging and Radiographic Detection of Erosions in Rheumatoid Arthritis. Arthritis and Rheumatism. S455-S456. 2012
- The Effect of Evaluation Variability At the Unit of Measurement On the Reliability of Omeract Ramris and Van Der Heijde-Modified Sharp Score.. Arthritis and Rheumatism. S440-S440. 2012
- Evidence for diminished skeletal load response in women who fracture early vs. those who fracture late in life. Bone. S125-S125. 2012
- Evidence for diminished skeletal load response in women who fracture early vs. those who fracture late in life. Bone. S65-S66. 2012
- Fracture Risk in Living Kidney Donors. American Journal of Transplantation. 504-504. 2012
- BONE AND MUSCLE CHANGES WITH TERIPARATIDE THERAPY FOR 18 MONTHS - A PILOT PROSPECTIVE STUDY FROM A CONVENIENCE COHORT. Osteoporosis International. S354-S355. 2012
- DENOSUMAB INCREASES TOTAL HIP BONE MINERAL DENSITY IN OLDER WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS. Osteoporosis International. S248-S249. 2012
- FIVE-YEAR INCIDENT FRACTURE RISK ASSESSED BY QUANTITATIVE MULTISITE ULTRASOUND: THE CANADIAN MULTICENTRE OSTEOPOROSIS STUDY. Osteoporosis International. S232-S232. 2012
- FRACTURE INCIDENCE IN OBESE POSTMENOPAUSAL WOMEN: THE GLOBAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW). Osteoporosis International. S71-S71. 2012
- LONG-TERM IMPACT OF ADHERENCE TO ORAL BISPHOSPHONATES ON OSTEOPOROTIC FRACTURE INCIDENCE. Osteoporosis International. S190-S191. 2012
- RELIABILITY OF PQCT-DERIVED MUSCLE AREA AND DENSITY MEASURES ON WATERSHED VS. THRESHOLD-BASED SEGMENTATION METHODS. Osteoporosis International. S238-S238. 2012
- Vitamin D in Obesity (VIDeO): Assessing Vitamin D Deficiency in the Bariatric Population. Arthritis and Rheumatism. S439-S439. 2011
- EFFECT OF CO-MORBIDITIES ON FRACTURE RISK: FINDINGS FROM THE GLOW STUDY. Osteoporosis International. S529-S530. 2011
- Participation in strenuous sports reduces stance stress at the medial femoral neck in Canadian men and women. Bone. S175-S176. 2011
- Peripheral quantitative ultrasound for the prediction of fracture over five years: The Canadian Multicentre Osteoporosis Study (CAMOS). Bone. S211-S211. 2011
- EFFECT OF ONCE-YEARLY ZOLEDRONIC ACID IN MEN AFTER RECENT HIP FRACTURE: RESULTS FROM HORIZON RECURRENT FRACTURE TRIAL. Osteoporosis International. 180-180. 2011
- DENOSUMAB REDUCED THE INCIDENCE OF HIP AND NEW VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH HIGHER FRACTURE RISK: A SUBANALYSIS OF THE FREEDOM STUDY. Osteoporosis International. S746-S747. 2010
- 411 CHANGES IN INTERMUSCULAR FAT AND MUSCLE VOLUME IN THE THIGHS OF WOMEN IN THE INCIDENT AND PROGRESSION COHORTS OF THE OAI. Osteoarthritis and Cartilage. S182-S182. 2010
- 444 ASSOCIATION BETWEEN THIGH MUSCLE VOLUME AND FEMUR BONE VOLUME IN WOMEN FROM THE OAI STUDY. Osteoarthritis and Cartilage. S199-S200. 2010
- CALCIUM AND VITAMIN D INTAKE IN RESIDENTS LIVING IN LONG-TERM-CARE (LTC) HOMES: THE VITAMIN D OSTEOPOROSIS STUDY (VIDOS). Osteoporosis International. 198-199. 2010
- CLINICAL RISK FACTORS FOR RECURRENT FRACTURE AFTER HIP FRACTURE. Osteoporosis International. 177-177. 2010
- DEFINING FRACTURE RISK IN WOMEN USING THE RECOMMENDATIONS FOR BONE MINERAL DENSITY (BMD) REPORTING IN CANADA. Osteoporosis International. 247-247. 2010
- HIGH VERSUS LOW DOSE VITAMIN D IN ACUTE HIP FRACTURE PATIENTS: A RANDOMISED, CONTROLLED TRIAL. Osteoporosis International. 201-201. 2010
- LOW ENERGY SUBTROCHANTERIC FRACTURES IN PATIENTS RECEIVING BISPHOSPHONATE THERAPY. Osteoporosis International. 362-362. 2010
- MECHANICAL LOADING MODULATES THE RELATIONSHIP BETWEEN AREAL BMD AND BONE STRUCTURE. Osteoporosis International. 241-242. 2010
- SUBTROCHANTERIC FRACTURES: RESULTS FROM THE HORIZON-RECURRENT FRACTURE TRIAL. Osteoporosis International. 23-23. 2010
- SUSTAINED EFFICACY OF BAZEDOXIFENE IN PREVENTING FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS OF A 5-YEAR, RANDOMIZED, PLACEBO-CONTROLLED STUDY. Osteoporosis International. 15-16. 2010
- USE OF BISPHOSPHONATE THERAPY IN RESIDENTS LIVING IN LONG-TERM-CARE (LTC) FACILITIES WHO ARE AT HIGH RISK FOR FRACTURES: THE VITAMIN D OSTEOPOROSIS STUDY (VIDOS). Osteoporosis International. 199-199. 2010
- ZOLEDRONIC ACID IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HIP FRACTURE: RESULTS OF HORIZON-RFT. Osteoporosis International. 151-151. 2010
- Clinical Risk Factors for Recurrent Fracture after Hip Fracture.. Journal of The American Geriatrics Society. 143-144. 2010
- Effect of Denosumab on Hip Fractures in Postmenopausal Women: A Subanalysis of the FREEDOM Study. Journal of The American Geriatrics Society. 24-24. 2010
- A Cross-Sectional Study on the Relation Between Clinical Characteristics and MRI Findings in the Hands of Rheumatoid Arthritis Patients - Preliminary Results. Journal of Rheumatology. 2607-2607. 2009
- Assessment of Fracture Risk and Treatment of Osteoporosis in Postmenopausal Women: Bone Density vs. BONE DESTINY (c). Journal of Rheumatology. 2562-2562. 2009
- Patients with Fragility Fracture Assessed by BMD, BONE DESTINY (c) and Osteoporosis Canada Guidelines. Journal of Rheumatology. 2562-2563. 2009
- Appropriate X-ray ordering depends on physician characteristics: Canadian Quality Circle (CQC) national project. Bone. S366-S367. 2009
- EFFECT OF ONCE-YEARLY IV ZOLEDRONIC ACID IN MEN AFTER HIP FRACTURE: RESULTS FROM THE HORIZON-RECURRENT FRACTURE TRIAL. Osteoporosis International. S271-S272. 2009
- Hip and vertebral fractures increase mortality rates in Canadians. Bone. S376-S377. 2009
- The impact of physician characteristics on bone mineral density ordering: Canadian Quality Circle (CQC) national project. Bone. S377-S377. 2009
- Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women. Bone. S108-S109. 2009
- ASSESSMENT OF FRACTURE RISK AND RECOMMENDATION FOR OSTEOPOROSIS TREATMENT IN WOMEN UNDERGOING THEIR FIRST DEXA SCAN: A COMPARISON BETWEEN BMD, BONE DESTINY AND OSTEOPOROSIS CANADA GUIDELINES. Osteoporosis International. S195-S195. 2009
- ASSESSMENT OF FRACTURE RISK AND TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN: A COMPARISON OF BMD, BONE DESTINY AND OC GUIDELINES. Osteoporosis International. S196-S196. 2009
- BONE DESTINY: A ONE-STEP GLOBAL FRACTURE RISK PREDICTOR FOR CLINICIANS. Osteoporosis International. S224-S225. 2009
- DISTRIBUTION OF RISK FACTORS FOR FRACTURE IN WOMEN WITH AND WITHOUT A FRACTURE HISTORY: A REGIONAL COMPARISON. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN. Osteoporosis International. S217-S218. 2009
- FAILURE TO PERCEIVE INCREASED RISK OF FRACTURE IN WOMEN 55 YEARS AND OLDER: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN. Osteoporosis International. S216-S217. 2009
- FRACTURE RISK ASSESSMENT AND TREATMENT RECOMMENDATIONS IN FEMALES WITH FRAGILITY FRACTURES ASSESSED BY BMD, BONE DESTINY AND OSTEOPOROSIS CANADA GUIDELINES. Osteoporosis International. S195-S196. 2009
- FRACTURE RISK ASSESSMENT AND TREATMENT RECOMMENDATIONS IN MALES WITH FRAGILITY FRACTURES ASSESSED BY BMD, BONE DESTINY AND OSTEOPOROSIS CANADA GUIDELINES. Osteoporosis International. S196-S197. 2009
- FRAGILITY FRACTURES AND HEALTH STATUS IN A MULTINATIONAL COHORT: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN. Osteoporosis International. S214-S214. 2009
- REGIONAL DIFFERENCES IN THE MANAGEMENT OF OSTEOPOROSIS: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN. Osteoporosis International. S205-S206. 2009
- RELIABILITY AND VALIDITY OF A MODIFIED VERSION OF THE SAFE FUNCTIONAL MOTION TEST-SHORT FORM FOR ASSESSING MOVEMENT PATTERNS IN INDIVIDUALS WITH LOW BONE MASS. Osteoporosis International. S221-S221. 2009
- RISK FACTORS FOR FRAGILITY FRACTURE IN A MULTIRACIAL COHORT OF US WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN. Osteoporosis International. S211-S212. 2009
- Failure to Perceive Increased Risk of Fracture in Women >= 55 Years. The Global Longitudinal study of Osteoporosis in Women. Journal of The American Geriatrics Society. S30-S31. 2009
- Absolute death rates by fracture type in Canadians. Arthritis and Rheumatism. S747-S747. 2008
- Attitudes to Fracture Prevention in Long-term Care Facilities: A Multicentre Study Examining the Opinions of Nursing Home Staff.. Journal of Bone and Mineral Research. S469-S469. 2008
- BONE DESTINY - A One Step Fracture Risk Predictor for Clinicians.. Journal of Bone and Mineral Research. S372-S373. 2008
- Comparison of 2D and 3D Subchondral Bone Texture Parameters in Severe OA Knees.. Journal of Bone and Mineral Research. S448-S448. 2008
- Distribution of Risk Factors for Fracture in Women With and Without a Fracture History: A Regional Comparison. The Global Longitudinal Registry of Osteoporosis in Women.. Journal of Bone and Mineral Research. S328-S328. 2008
- Family Physician Characteristics that Predict Appropriate X-ray Ordering: Canadian Quality Circle (CQC) National Project. Journal of Bone and Mineral Research. S200-S201. 2008
- Fractures of the Spine and Hip Increase the Risk of Death in Canadians.. Journal of Bone and Mineral Research. S331-S331. 2008
- Normative Z-scores from the Canadian Multicentre Osteoporosis Study Youth Cohort.. Journal of Bone and Mineral Research. S315-S315. 2008
- Patients with Fragility Fracture Assessed by BNID, Bone DESTINY and Osteoporosis Canada Guidelines. Journal of Bone and Mineral Research. S198-S198. 2008
- Relationship between compartmental and mid-subchondral tibial bone texture in knees with severe osteoarthritis. Arthritis and Rheumatism. S240-S240. 2008
- Strategies for Hip Fracture Prevention in Long-term Care Facilities: A Survey of Canadian Geriatricians and Family Physicians.. Journal of Bone and Mineral Research. S469-S469. 2008
- The Population Burden of First and Repeat Low-trauma Fractures: The Canadian Multicentre Osteoporosis Study.. Journal of Bone and Mineral Research. S17-S17. 2008
- The impact of rib fractures on health related quality of life is underestimated. Arthritis and Rheumatism. S744-S744. 2008
- Treating Osteoporosis in the Elderly: An Environmental Scan of Nursing Home Prescribing in Ontario, Canada.. Journal of Bone and Mineral Research. S345-S345. 2008
- Treatment Discontinuation Due to Gastrointestinal Adverse Events and Decreased Bone Mineral Density in Patients Switched from Branded Alendronate to Generic Alendronate.. Journal of Bone and Mineral Research. S210-S210. 2008
- Timing of first infusion of zoledronic acid 5 mg after recent hip fracture affects antifracture efficacy and reduction of mortality. Calcified Tissue International. 8-8. 2008
- Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, phase III, placebo- and active-controlled study. Journal of Rheumatology. 1189-1189. 2008
- Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial. Journal of Rheumatology. 1190-1190. 2008
- Oncogenic osteomalacia. A case report and literature review. Journal of Rheumatology. 1200-1201. 2008
- Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. Journal of The American Geriatrics Society. S17-S17. 2008
- Early and sustained non-vertebral fracture efficacy with risedronate. Bone. S76-S77. 2008
- An environmental scan of osteoporosis management in Canadian nursing homes. Calcified Tissue International. S232-S233. 2008
- Family physicians use of non-pharmacological interventions increases following the Canadian quality circle (CQC) national project. Calcified Tissue International. S230-S231. 2008
- Family physicians' X-ray ordering patterns improve in high risk patients following the Canadian quality circle (CQC) national project. Calcified Tissue International. S171-S172. 2008
- Family physicians' utilization of appropriate bone mineral density testing improved following the national Canadian quality circle (CQC) project. Calcified Tissue International. S172-S172. 2008
- Incident fractures predict mortality: The Canadian Multicentre Osteoporosis Study (CAMOS). Calcified Tissue International. S229-S230. 2008
- Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial. Calcified Tissue International. S210-S211. 2008
- Significant reduction in non-vertebral fractures with intravenous ibandronate injection: Post-hoc analysis of the diva trial. Calcified Tissue International. S210-S210. 2008
- The timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: Results from horizon-recurrent fracture trial. Calcified Tissue International. S41-S41. 2008
- Treatment increases in patients with osteopenia and prior fractures following the Canadian Quality Circle (CQC) national project. Calcified Tissue International. S230-S230. 2008
- 5 year incidence of fractures in patients with severe osteoporosis: The Canadian Multicentre osteoporosis study (CaMos). Journal of Bone and Mineral Research. S432-S432. 2007
- A five year longitudinal study of health related quality of life in individuals with and without incident fractures: The Canadian Multicentre osteoporosis study (CaMos). Journal of Bone and Mineral Research. S314-S314. 2007
- A meta-analysis of individual patient data: Significant reduction in non-vertebral fractures with high- versus low-dose ibandronate. Journal of Bone and Mineral Research. S210-S211. 2007
- Associations between bone mineral density and speed of sound: Canadian Multicentre osteoporosis study. Journal of Bone and Mineral Research. S305-S305. 2007
- Bisphosphonate use increases in patients with osteopenia and prior fractures following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) national project. Journal of Bone and Mineral Research. S331-S331. 2007
- Bisphosphonate use increases in patients with osteoporosis following an integrated osteoporosis educational intervention: Canadian Quality Circle (CQC) National Project.. Journal of Bone and Mineral Research. S212-S212. 2007
- CFOS trial: Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients. Journal of Bone and Mineral Research. S452-S452. 2007
- Canadian normative data for sunlight omnisense quantitative ultrasound: Canadian Multicentre osteoporosis study. Journal of Bone and Mineral Research. S306-S306. 2007
- Early and sustained non-vertebral fracture efficacy with risedronate. Journal of Bone and Mineral Research. S212-S213. 2007
- Fragility fracture increases antidepressant use among women 65 years of age and older. Journal of Bone and Mineral Research. S211-S211. 2007
- Identifying the treatment care gap in postmenopausal women at the southlake regional health centre: The role of a "Shared Care" model. Journal of Bone and Mineral Research. S456-S456. 2007
- Morphometric vertebral fracture status and WHO predictors of fracture risk. Journal of Bone and Mineral Research. S121-S121. 2007
- Peripheral quantitative computed tomography (pQCT) reproducibility of volumetric bone density measurements at the radius and tibia in healthy women. Journal of Bone and Mineral Research. S194-S194. 2007
- Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial. Journal of Bone and Mineral Research. S460-S460. 2007
- Trends in femur structural strength with aging in Canadian adults: 2 Canadian multicentre osteoporosis study. Journal of Bone and Mineral Research. S420-S421. 2007
- X-ray ordering improves in patients with height loss or kyphosis following an osteoporosis educational intervention: Canadian Quality Circle (CQC) national project. Journal of Bone and Mineral Research. S313-S313. 2007
- Teriparatide improves osteoporosis related fracture pain. Bone. S22-S22. 2007
- Depressive symptoms did not predict incident fractures in the Canadian multicentre osteoporosis study.. Journal of The American Geriatrics Society. S144-S145. 2007
- Primary care physicians utilization of drug therapies improves in patients with severe osteoporosis following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) pilot project. Osteoporosis International. S230-S231. 2007
- Medial tibial and femoral cartilage volume and thickness measurements correlate with pain and function in individuals with knee OA. Osteoporosis International. S62-S63. 2007
- Minimum joint space width values in healthy individuals and patients with knee OA. Osteoporosis International. S13-S14. 2007
- The contribution of medial femoral and tibial cartilage thickness to minimum joint space width in osteoarthritic knees. Osteoporosis International. S13-S13. 2007
- Appropriate bone mineral density testing following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) national project. Calcified Tissue International. S132-S132. 2007
- Drug therapy utilization improves in patients with severe following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) pilot project. Calcified Tissue International. S114-S114. 2007
- Primary care physicians perceived certainty of their patients risk factor status increases following a multifaceted osteoporosis educational intervention: Canadian Quality Circle (CQC) national project. Calcified Tissue International. S140-S141. 2007
- Primary care physicians' preferences to bisphosphonate therapies in patients with severe osteoporosis following a multifaceted osteoporosis educational intervention: Canadian Quality Circle (CQC) pilot project. Calcified Tissue International. S135-S135. 2007
- Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients.. Journal of Bone and Mineral Research. S416-S416. 2006
- Costs of fragility fractures among men are considerable in managed care.. Arthritis and Rheumatism. S82-S82. 2006
- Family physicians' utilization of calcium and vitamin D in patients with fractures following an educational intervention: Canadian quality circle (CQC) national project.. Arthritis and Rheumatism. S84-S84. 2006
- It could happen to me: Perceptions of future fracture risk in individuals with a history of fragility fracture.. Journal of Bone and Mineral Research. S406-S406. 2006
- Medial tibial and femoral cartilage volume and thickness measurements correlate with pain and function in individuals with knee OA.. Arthritis and Rheumatism. S152-S152. 2006
- Minimum joint space width values in healthy individuals and patients with knee OA.. Arthritis and Rheumatism. S151-S151. 2006
- Prognostic factors for first clinical fracture in patients with primary osteoporosis: Data from the Canadian database of osteoporosis and osteopenia (CANDOO).. Journal of Bone and Mineral Research. S108-S108. 2006
- Risedronate treatment produces a significant reduction in the risk of clinical vertebral fractures over 3 years.. Arthritis and Rheumatism. S82-S82. 2006
- Symptoms correlate with radiographic measures of disease severity in those with knee osteoarthritis.. Arthritis and Rheumatism. S152-S152. 2006
- The association among risk factors for fracture and family physicians' beliefs that their patients are at high risk for a future fracture: Canadian quality circle (CQC) national project.. Journal of Bone and Mineral Research. S278-S278. 2006
- The cost-effectiveness of calcium and Vitamin D or hormone replacement therapy in the prevention of osteoporotic fractures in Canadian postmenopausal women.. Journal of Bone and Mineral Research. S279-S279. 2006
- The rate that family physicians prescribe calcium and Vitamin D to their patients with fractures following an educational intervention: Canadian Quality Circle (CQC) national project.. Journal of Bone and Mineral Research. S307-S307. 2006
- The relationship among key risk factors for fracture and family physicians' beliefs that their patients have osteoporosis: Canadian quality circle (CQC) National Project.. Journal of Bone and Mineral Research. S407-S407. 2006
- The use of selective serotonin reuptake inhibitors and fragility fractures: Results from the CaMos study. Osteoporosis International. 952-952. 2006
- A comparison of fracture risk classification systems and estimated rates of treatable osteoporosis. Osteoporosis International. S148-S148. 2006
- Appropriateness of care in osteoporotic and elevated risk patients in Canada: The expertmd in osteoporosis project. Osteoporosis International. S190-S191. 2006
- Bisphosphonate use in elderly nursing home residents. Osteoporosis International. S239-S239. 2006
- Bone erosions detected by peripheral mri at the metacarpophalangeal (MCP) and wrist joints in subjects with and without rheumatoid arthritis. Osteoporosis International. S292-S293. 2006
- Compliance, acceptance, and safety of teriparatide injection over 18 months in patients with severe osteoporosis. Osteoporosis International. S236-S236. 2006
- Costs of fragility fractures among men are considerable in managed care. Osteoporosis International. S173-S173. 2006
- Dedicated RF coil design for 1T magnetic resonance imaging of trabecular bone at distal radius. Osteoporosis International. S275-S275. 2006
- Do patients with fragility fractures perceive themselves to be at risk of future fracture?. Osteoporosis International. S180-S181. 2006
- Economic evaluation of aclasta (R) (zoledronic acid 5 mg) versus actonel (R) (risedronate) in treatment of Paget's disease. Osteoporosis International. S189-S189. 2006
- Expanding the clinical picture of osteoporosis. Osteoporosis International. S358-S358. 2006
- Family physicians' awareness of key risk factors for fracture and the use of bone mineral density (BMD) testing following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) national project. Osteoporosis International. S274-S274. 2006
- Family physicians' utilization of bone mineral density (BMD) testing in patients with key risk factors following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) pilot project. Osteoporosis International. S136-S136. 2006
- Fragility fracture prevalence in women and men according to T-score values: The Canadian multicentre osteoporosis study (CAMOS). Osteoporosis International. S151-S152. 2006
- Low rates of vitamin D supplementation in Canadians with low bone mass or fractures. Osteoporosis International. S229-S229. 2006
- Magnetic resonance imaging scoring system for knee disorders in patients with osteoarthritis or anterior cruciate ligament injury. Osteoporosis International. S293-S293. 2006
- Measures of distal radial bone geometry predict fracture load. Osteoporosis International. S279-S279. 2006
- Osteoporosis information needs and preferences in fragility fracture patients. Osteoporosis International. S181-S181. 2006
- Quality of life in patients with osteoporosis: Assessment of pain and function. Osteoporosis International. S356-S356. 2006
- The rate that family physicians prescribe bisphosphonates to their patients: Canadian quality circles (CQC) national project. Osteoporosis International. S232-S232. 2006
- Articular cartilage volume and thickness measurements correlate with pain and function in individuals with medial tibiofemoral knee OA. Osteoporosis International. S10-S11. 2006
- Economic evaluation of Aclasta (TM) (zoledronic acid 5 mg) versus Actonel (TM) (risedronate) in treatment of Paget's disease. Osteoporosis International. S38-S39. 2006
- Medial tibiofemoral minimum joint space width measurements correlate with pain and function in individuals with knee OA. Osteoporosis International. S24-S25. 2006
- Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre Osteoporosis Study (CaMOS).. Journal of Rheumatology. 377-377. 2006
- A meta-analysis of hip protector trials in institutionalized elderly using a Bayesian approach.. Journal of Bone and Mineral Research. S290-S290. 2005
- Barriers and facilitators to osteoporosis medication adherence: Patient perceptions and strategies.. Journal of Bone and Mineral Research. S405-S406. 2005
- Family physicians' awareness of fracture, the appropriate utilization of bone mineral density testing, and the rate that bisphosphonates are prescribed to their patients with fracture: Canadian Quality Circle (CQC) Pilot Project.. Arthritis and Rheumatism. S421-S422. 2005
- Family physicians' awareness of key osteoporosis risk factors and the utilization of bone mineral density (BMD) testing following a multifaceted osteoporosis educational intervention: Canadian quality circle (CQC) pilot project.. Journal of Bone and Mineral Research. S386-S386. 2005
- Knowledge dissemination strategies translate into improved post-fracture osteoporosis care. Journal of Bone and Mineral Research. S264-S264. 2005
- Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre osteoporosis study (CaMOS).. Journal of Bone and Mineral Research. S121-S121. 2005
- Risedronate demonstrates antifracture efficacy over a range of baseline BMD levels.. Journal of Bone and Mineral Research. S400-S400. 2005
- Risedronate demonstrates efficacy over a wide range of risk for osteoporotic fracture.. Arthritis and Rheumatism. S291-S291. 2005
- Similar proportions of women lose bone mineral density with raloxifene or alendronate treatment. Journal of Clinical Densitometry. 273-277. 2005
- The economic implications of a policy of provision of hip protectors to institutionalized elderly in Ontario, Canada.. Journal of Bone and Mineral Research. S290-S290. 2005
- The evaluation of process factors involved in performing the Canadian Quality Circle (CQC) Pilot Project for the care of patients at risk for osteoporosis.. Journal of Bone and Mineral Research. S278-S278. 2005
- The rate that family physicians prescribe osteoporosis medications to their patients: Canadian Quality Circles (CQC) Project.. Journal of Bone and Mineral Research. S278-S278. 2005
- Treatment-related changes in BMD are not associated with the occurrence of a fragility fracture while on risedronate therapy. Journal of Bone and Mineral Research. S169-S169. 2005
- Family physicians' awareness of osteoporosis risk factors and utilization of bone mineral density (BMD) screening following a multifaceted osteoporosis intervention strategy: Canadian quality circle (CQC) pilot project. Bone. S357-S357. 2005
- Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre Osteoporosis Study (CaMoS). Bone. S343-S344. 2005
- The assessment of process factors involved in conducting the Canadian Quality Circle (CQC) pilot project for the care of patients at risk for osteoporosis (OP). Bone. S339-S339. 2005
- The rate that family physicians prescribe osteoporosis medications to their patients: Canadian Quality Circles (CQC) Project. Bone. S405-S406. 2005
- Vertebral fracture risk reduction is independent of the magnitude of BMD change. Osteoporosis International. S53-S54. 2004
- A multi-faceted post-fracture care model: The fracture? Think osteoporosis! Program.. Journal of Bone and Mineral Research. S318-S318. 2004
- Detection of prevalent vertebral fractures using historical height loss: Comparison of different height measurement methods.. Journal of Bone and Mineral Research. S161-S161. 2004
- Evaluation of easily measured risk factors in the prediction of osteoporotic fractures.. Journal of Bone and Mineral Research. S90-S90. 2004
- Family physician awareness of risk factors for fracture and the appropriate use of bone mineral density screening in accordance with the Canadian osteoporosis guidelines: Canadian Quality Circles (CQC) Project.. Journal of Bone and Mineral Research. S166-S166. 2004
- Health Utilities Index 3 scores in osteoporosis compared to other chronic medical conditions: A population-based study from the Canadian Multicentre Osteoporosis Study (CaMos).. Journal of Bone and Mineral Research. S180-S180. 2004
- High prevalence of fracture in young adults with cystic fibrosis.. Journal of Bone and Mineral Research. S294-S294. 2004
- Study design of the Canadian quality circle (CQC) pilot project in osteoporosis. Journal of Bone and Mineral Research. S428-S428. 2004
- The number of Canadian men and women needed to be screened to detect a case of osteoporosis: A population-based study from the Canadian Multicentre osteoporosis study (CaMos). Journal of Bone and Mineral Research. S368-S368. 2004
- The rate that family physicians prescribe pharmacological treatment to their patients: Canadian quality circles (CQC) project.. Journal of Bone and Mineral Research. S440-S441. 2004
- Measurements of health-related quality of life using the health utilities index 3 in Canadian women: The impact of self-reported osteoporosis in the Canadian multicentre osteoporosis study (CaMos). Arthritis and Rheumatism. S49-S50. 2004
- Prevalence of undiagnosed osteoporosis in Canadians age 65 years and older: the Canadian Multicentre Osteoporosis Study (CaMos).. Arthritis and Rheumatism. S268-S268. 2004
- Serial knee radiographic changes can be followed using 2 medial minimum joint space width.. Arthritis and Rheumatism. S350-S350. 2004
- The usefulness of seven easily measureable risk factors for early recognition of future osteoporotic fracture. Arthritis and Rheumatism. S290-S290. 2004
- What is the probability a new vertebral fracture is present? Data from the MORE and fracture prevention trials. Arthritis and Rheumatism. S292-S292. 2004
- Characteristics that predict new fragility non-vertebral fracture in postmenopausal women who are enrolled in the Canadian Multicentre Osteoporosis Study (CaMos). Journal of Rheumatology. 1437-1438. 2004
- Impact of non-compliance and non-persistence with daily bisphosphonates on longer-term effectiveness outcomes in patients with osteoporosis treated in tertiary specialist care. Annals of the Rheumatic Diseases. 96-97. 2004
- Inability to rise from a chair predicts hip fracture in clinical practice. Journal of Aging and Physical Activity. 269-270. 2004
- Participant characteristics of postmenopausal women that predict new clinically recognized vertebral fracture in a three-year observational study: The Canadian Multicentre Osteoporosis Study (CAMOS).. Journal of Rheumatology. 1437-1437. 2004
- Rapid resolution of the reduction of bone turnover markers after discontinuation of risedronate in postmenopausal women with osteoporosis previously treated for 2 years.. Journal of Rheumatology. 1430-1430. 2004
- Magnitude of BMD change is a poor predictor of vertebral fracture risk reduction. Osteoporosis International. 508-509. 2004
- Bone and Muscle Relations in Elite Adolescent Male Cross-Country Skiers. Medicine & Science in Sports & Exercise. S155-S155. 2004
- Longer term effectiveness outcomes of noncompliance and nonpersistence with daily regimen bisphosphonate therapy in patients with osteoporosis treated in tertiary specialist care. Osteoporosis International. S107-S107. 2004
- Rapid resolution of the reduction of bone turnover markers after discontinuation of risedronate in postmenopausal women with osteoporosis previously treated for 2 years. Osteoporosis International. S16-S16. 2004
- Normal values of medial tibiofemoral minimum joint space width in the knees of healthy men and women. Osteoarthritis and Cartilage. S65-S66. 2004
- PROPORTION OF BMD RESPONDERS IS SIMILAR WITH RALOXIFENE AND ALENDRONATE. Calcified Tissue International. S89-S89. 2004
- RAPID RESOLUTION OF THE REDUCTION OF BONE TURNOVER MARKERS AFTER DISCONTINUATION OF RISEDRONATE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS PREVIOUSLY TREATED FOR 2 YEARS. Calcified Tissue International. S100-S100. 2004
- The association between patient-reported pain and magnetic resonance imaging (MRI) of the knee. Osteoarthritis and Cartilage. S66-S67. 2004
- The association between physical examination and magnetic resonance imaging (MRI) of the knee. Osteoarthritis and Cartilage. S120-S121. 2004
- VERTEBRAL FRACTURE RISK REDUCTION IS INDEPENDENT OF THE MAGNITUDE OF BMD CHANGE. Calcified Tissue International. S79-S80. 2004
- Validation of quantitative cartilage measurements on a 1 T extremity MRI system. Osteoarthritis and Cartilage. S62-S62. 2004
- Both oral and intravenous ibandronate effectively prevent postmenopausal bone loss in women without osteoporosis.. Journal of Bone and Mineral Research. S372-S372. 2003
- Characteristics that predict new fragility non-vertebral fracture in postmenopausal women who are enrolled in the Canadian Multicentre osteoporosis study (CaMos).. Arthritis and Rheumatism. S82-S83. 2003
- Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.. Journal of Bone and Mineral Research. S379-S379. 2003
- Fracture risk reduction due to antiresorptive treatment is independent of the magnitude of BMD improvement.. Arthritis and Rheumatism. S84-S84. 2003
- Men have a higher rate of prevalent fractures compared to women when started on bisphosphonate therapy: The Canadian Database of Osteoporosis and Osteopenia.. Arthritis and Rheumatism. S299-S299. 2003
- Men present with a higher rate of prevalent fractures than women when started on bisphosphonate therapy in Canadian specialty osteoporosis practices.. Journal of Bone and Mineral Research. S364-S364. 2003
- Participant characteristics of postmenopausal women that predict new clinically recognized vertebral fracture in a three-year observational study: The Canadian Multicentre osteoporosis study (CaMos). Arthritis and Rheumatism. S82-S82. 2003
- Participant characteristics that predict new clinically recognized vertebral fracture in postmenopausal women: The Canadian Multicentre Osteoporosis Study (CaMos).. Journal of Bone and Mineral Research. S246-S246. 2003
- Predicting previous fracture with the health utilities index (HUI) mark II and III systems in both women and men: The Canadian Multicentre osteoporosis study (CaMos).. Journal of Bone and Mineral Research. S249-S249. 2003
- Predictors of early failure of bisphosphonate therapy: The Canadian database of osteoporosis and osteopenia (CANDOO).. Arthritis and Rheumatism. S449-S449. 2003
- Risk factors associated with quality of life (QOL) in postmenopausal women with prevalent vertebral fractures: the Canadian database of osteoporosis and osteopenia (CANDOO).. Arthritis and Rheumatism. S83-S83. 2003
- Risk factors related with quality of life (QOL) in postmenopausal women with prevalent vertebral fractures: The Canadian Database of Osteoporosis and Osteopenia (CANDOO).. Journal of Bone and Mineral Research. S247-S247. 2003
- Risk factors that predict new non-vertebral fracture in postmenopausal women: The Canadian Multicentre Osteoporosis Study (CaMos).. Journal of Bone and Mineral Research. S246-S246. 2003
- The human cost of fractures in community dwelling older adults.. Journal of Bone and Mineral Research. S247-S247. 2003
- The human cost of fractures in community dwelling older adults.. Arthritis and Rheumatism. S301-S301. 2003
- The relations between lumbar spine, hip, distal femur and proximal tibia bone mineral density in healthy individuals.. Journal of Bone and Mineral Research. S187-S187. 2003
- The relations between minimum joint space width in the knee and bone mineral density in the spine, hip, distal femur and proximal tibia.. Journal of Bone and Mineral Research. S288-S288. 2003
- Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: A comparative review. Journal of Rheumatology. 1883-1883. 2003
- Nonvertebral fracture risk is significantly reduced with risedronate treatment in just one year. Journal of Rheumatology. 1886-1886. 2003
- Once-a-week risedronate is effective in reducing vertebral fracture risk. Journal of Rheumatology. 1877-1877. 2003
- Patient characteristics that predict the time to first clinically recognized vertebral deformity in postmenopausal women enrolled the Canadian multicentre osteoporosis study (CaMos). Bone. S187-S188. 2003
- Risk factors that predict the time to first nonvertebral fracture in postmenopausal women recruited from the Canadian multicentre osteoporosis study (CaMos). Bone. S188-S188. 2003
- The association between osteoporotic fractures and health related quality of life (HRQL) as measured by the health utilities index Mark II and Mark III systems. Bone. S175-S175. 2003
- Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross-Sectional Results From the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research. 784-790. 2003
- Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: The aware survey. Osteoporosis International. S60-S61. 2003
- Imaging abnormalities in the knee of asymptomatic individuals identified using peripheral MRI. Osteoporosis International. S39-S39. 2003
- Risk factors that predict new fractures in postmenopausal women: The Canadian database for osteoporosis and osteopenia (CANDOO). Osteoporosis International. S7-S7. 2003
- The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women. Osteoporosis International. S84-S85. 2003
- The effectiveness of etidronate and alendronate in the treatment of osteoporosis in women with a history of breast cancer: The Canadian database for osteoporosis and osteopenia (CANDOO). Osteoporosis International. S41-S41. 2003
- The relations between bone mineral density in the spine, hip, distal femur and proximal tibia and medial minimum joint space width in the knees of healthy men and women. Osteoporosis International. S36-S36. 2003
- Vertebral fracture risk reduction with risedronate in postmenopausal women with osteoporosis: A meta-analysis of individual patient data. Osteoporosis International. S61-S61. 2003
- Adherence profile of etidronate (ETD), alendronate (ALD) and hormone replacement therapy (HRT) in patients registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO).. Journal of Bone and Mineral Research. S270-S270. 2002
- CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up. Journal of Bone and Mineral Research. S358-S358. 2002
- Prevalence and severity of vertebral fractures among patients with chronic obstructive pulmonary disease (COPD) in Canada.. Journal of Bone and Mineral Research. S460-S460. 2002
- Relation between disease activity and apparent trabecular texture at the wrist in individuals with rheumatoid arthritis.. Journal of Bone and Mineral Research. S232-S232. 2002
- Secondary causes of osteoporosis in patients registered in the Canadian database of osteoporosis and osteopenia (CANDOO).. Journal of Bone and Mineral Research. S261-S261. 2002
- The impact of dropouts on the efficacy of 5 mg risedronate: An assessment based on an imputation analysis. Journal of Bone and Mineral Research. S369-S369. 2002
- The influence of bone mineral density (BMD) testing on the treatment of osteoporosis (OP) in two Canadian non-academic community centres.. Journal of Bone and Mineral Research. S414-S414. 2002
- The relationship between prospective height loss and multiple vertebral fractures.. Journal of Bone and Mineral Research. S155-S155. 2002
- The utility of prospective height loss for detecting vertebral fracture depends on fracture incidence. Journal of Bone and Mineral Research. S201-S201. 2002
- CANDOO: A longitudinal canadian multicenter tertiary-care network for observational research in osteoporosis (OP) and osteopenia using standardized clinical practice data: 11 years of follow-up. Osteoporosis International. S28-S28. 2002
- Iliocostal distance (ILCD) is associated with prevalent vertebral (VERT) and non-vertebral (NV) fractures in patients registered in the Canadian database of osteoporosis and osteopenia (CANDOO). Osteoporosis International. S79-S79. 2002
- Once-a-week (35 mg) risedronate is as effective as daily (5 mg). Osteoporosis International. S16-S16. 2002
- The accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporosis International. S71-S71. 2002
- The prevalence of secondary causes of osteoporosis. Osteoporosis International. S136-S137. 2002
- What is the morbidity of mild vertebral fractures?. Osteoporosis International. S35-S35. 2002
- CANDOO: A longitudinal Canadian multi-center tertiary-care network for observational research in osteoporosis and osteopenia using standardized clinical practice data: 11 years of follow-up.. Arthritis and Rheumatism. S257-S257. 2001
- Development and evaluation of a decision aid for women with established osteoporosis.. Journal of Bone and Mineral Research. S412-S412. 2001
- Lengthy hospitalizations associated with vertebral fractures despite control for comorbid conditions.. Journal of Bone and Mineral Research. S392-S392. 2001
- PTH treatment directly stimulates bone formation in cancellous and cortical bone in humans.. Journal of Bone and Mineral Research. S179-S179. 2001
- Prevalence of vertebral fracture among patients with Chronic Obstructive Pulmonary Disease (COPD) in Canada.. Journal of Bone and Mineral Research. S389-S389. 2001
- Significance of vertebral deformity as indicated by the SF-36 quality of life measures.. Journal of Bone and Mineral Research. S392-S392. 2001
- The impact of co-morbid conditions on bone mineral density and vertebral deformities in community dwelling men and women across Canada.. Journal of Bone and Mineral Research. S520-S520. 2001
- The impact of osteoporotic fractures on Health Related Quality of Life (HRQL) as measured by the health utilities index.. Arthritis and Rheumatism. S255-S255. 2001
- The impact of osteoporotic fractures on health related quality of life (HRQL) as measured by the health utilities index.. Journal of Bone and Mineral Research. S393-S393. 2001
- The impact of treatment interventions on health related quality of life (HRQL) in post-menopausal women registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients.. Journal of Bone and Mineral Research. S541-S541. 2001
- The impact of treatment interventions on health related qualtiy of life (HRQL) in post-menopausal women registered in the Canadian database of osteoporosis and osteopenia (CANDOO) patients.. Arthritis and Rheumatism. S257-S257. 2001
- Twelve month efficacy of home-based exercise for improving the quality of life of elderly women with symptomatic osteoporosis related vertebral fractures.. Journal of Bone and Mineral Research. S409-S409. 2001
- Risedronate is well-tolerated in postmenopausal women who are GI-intolerant to alendronate. Bone. S228-S228. 2001
- The effects of treatment interventions on health related quality of life (HRQL) in post-menopausal women registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients. Bone. S241-S241. 2001
- Discrimination of changes in osteoporosis outcomes.. Journal of Rheumatology. 413-421. 2001
- Seropositive symmetrical inflammatory polyarthritis appearing after treatment with fludarabine in a patient with non-Hodgkin's lymphoma.. Blood. 241B-241B. 2000
- Assessment of apparent trabecular bone porosity at the distal radius in women matched for bone density discriminates individuals with recent wrist fractures from those without fracture.. Journal of Bone and Mineral Research. S184-S184. 2000
- Canadian male normative speed of sound (SOS) database for the sunlight omnisense bone sonometer.. Journal of Bone and Mineral Research. S407-S407. 2000
- Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: A prospective observational study.. Arthritis and Rheumatism. S205-S205. 2000
- Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: a prospective observational study.. Journal of Bone and Mineral Research. S308-S308. 2000
- Efficacy of home-based exercise for improving the physical functioning of elderly women with symptomatic osteoporosis-related vertebral fractures.. Journal of Bone and Mineral Research. S437-S437. 2000
- Non-vertebral fractures and quality of life.. Arthritis and Rheumatism. S397-S397. 2000
- Non-vertebral fractures and quality of life.. Journal of Bone and Mineral Research. S562-S562. 2000
- Patient adherence to bisphosphonate therapy.. Journal of Bone and Mineral Research. S433-S433. 2000
- Patient adherence to bisphosphonate therapy.. Arthritis and Rheumatism. S201-S201. 2000
- Re-fracture one year following hip fracture in Canada.. Journal of Bone and Mineral Research. S294-S294. 2000
- Risk factors associated with osteoporosis in developmentally disabled adults.. Journal of Bone and Mineral Research. S417-S417. 2000
- Tolerability of risedronate in alendronate-intolerant postmenopausal women.. Arthritis and Rheumatism. S202-S202. 2000
- Vertebral fractures and quality of life.. Arthritis and Rheumatism. S199-S199. 2000
- Vertebral fractures and quality of life.. Journal of Bone and Mineral Research. S562-S562. 2000
- Effect of vitamin D in patients with declining vertebral bone mineral density despite stable bisphosphonate therapy. Osteoporosis International. S182-S182. 2000
- Effectiveness of etidronate and alendronate in the treatment of osteoporosis in males: A prospective observational study. Osteoporosis International. S199-S199. 2000
- Patient compliance with bisphosphonate therapy. Osteoporosis International. S200-S200. 2000
- Vertebral fractures and quality of life. Osteoporosis International. S200-S200. 2000
- How were patients with BMD results managed by their primary care physicians from 1992 to 1995.. Journal of Bone and Mineral Research. S381-S381. 1999
- Impact of first-time bone mineral density testing on osteoporosis-related treatment patterns in 2 non-academic settings.. Journal of Bone and Mineral Research. S529-S529. 1999
- In vivo distal radius bone structure measurements.. Journal of Bone and Mineral Research. S431-S431. 1999
- Longer stay when vertebral fractures co-exist with other health problems necessitating hospitalization.. Journal of Bone and Mineral Research. S259-S259. 1999
- Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.. Arthritis and Rheumatism. S290-S290. 1999
- The influence of osteoporotic fractures on health related quality of life (HRQL) in community dwelling men and women across Canada.. Journal of Bone and Mineral Research. S262-S262. 1999
- The relationship between fracture and other variables in the Hamilton subset of the Canadian Multicentre Osteoporosis Study dataset determined through a pattern discovery algorithm.. Journal of Bone and Mineral Research. S260-S260. 1999
- Addition of bisphosphonate therapy with etidronate or alendronate to stable estrogen replacement therapy in postmenopausal women increases lumbar spine and femoral trochanter bone mineral density.. Arthritis and Rheumatism. S44-S44. 1998
- Cochrane review of alendronate for prevention and treatment of postmenopausal osteoporosis. Arthritis and Rheumatism. S134-S134. 1998
- Cochrane review on fluoride therapy to prevent postmenopausal osteoporosis. Arthritis and Rheumatism. S134-S134. 1998
- Etidronate in the prevention of corticosteroid-induced osteoporosis: One year of follow-up on calcium only.. Arthritis and Rheumatism. S137-S137. 1998
- Intermittent cyclical therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up.. Arthritis and Rheumatism. S302-S302. 1998
- Prevention of corticosteroid-induced osteoporosis with etidronate: Pooled results from two clinical trials.. Arthritis and Rheumatism. S303-S303. 1998
- The effect of etidronate on lumbar spine bone mineral density in men.. Arthritis and Rheumatism. S44-S44. 1998
- Intermittent cyclical therapy with etidronate in the prevention of corticosteroid-induced osteoporosis.. Arthritis and Rheumatism. 1773-1773. 1997
- An open-label, multicentre trial on intermittent cyclical therapy with etidronate in postmenopausal osteoporotic women.. Journal of Bone and Mineral Research. S485-S485. 1997
- Bone mass and structure measurements by DXA, pQCT and ultrasound at the hip, spine, radius and heel in women who are osteoporotic or osteopenic. Journal of Bone and Mineral Research. S569-S569. 1997
- Bone turnover markers predict changes in bone mineral density in patients treated with corticosteroids.. Journal of Bone and Mineral Research. S635-S635. 1997
- Comparison of BMD measurements at 6 and 12 months in assessing response to etidronate in osteoporosis. Journal of Bone and Mineral Research. S486-S486. 1997
- Effects of education on decisions to start hormone therapy by postmenopausal women at risk for fractures.. Journal of Bone and Mineral Research. F505-F505. 1997
- Etidronate therapy in patients on high dose corticosteroids: Differences in bone resorption marker responses.. Journal of Bone and Mineral Research. S626-S626. 1997
- Fluoride therapy in the prevention of rheumatoid arthritis induced bone loss.. Journal of Bone and Mineral Research. S641-S641. 1997
- How commonly do physicians attribute: Hip fractures to osteoporosis in acute care?. Journal of Bone and Mineral Research. T601-T601. 1997
- Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up. Journal of Bone and Mineral Research. S630-S630. 1997
- Intermittent cyclical etidronate therapy for the prevention of rheumatoid arthritis induced bone loss following 18 months of fluoride therapy or placebo.. Journal of Bone and Mineral Research. S642-S642. 1997
- Intermittent cyclical therapy with etidronate prevents bone loss in corticosteroid treated patients and reduces fracture rate in a subgroup of postmenopausal women.. Journal of Bone and Mineral Research. P267-P267. 1997
- Peripheral quantitative computed tomography measurements of normal human bone mass and structure.. Journal of Bone and Mineral Research. T641-T641. 1997
- Risedronate treatment improves pain status in patients with Pagets disease of bone. Journal of Bone and Mineral Research. T673-T673. 1997
- Risedronate vs. etidronate Pagets study: Durable remission with only two months of 30 mg risedronate. Journal of Bone and Mineral Research. T670-T670. 1997
- Where do Canadian hip fracture patients go one year post discharge from acute care hospitals, and what is the cost of their follow-up care?. Journal of Bone and Mineral Research. F560-F560. 1997
- A randomized, double-blind, placebo-controlled trial of the effects of fluoride on lumbar spine bone mineral density in patients with rheumatoid arthritis.. Arthritis and Rheumatism. 661-661. 1996
- How common is vitamin D deficiency in Canadian women living in the community?. Arthritis and Rheumatism. 672-672. 1996
- What is the yield of screening for secondary causes of osteoporosis?. Arthritis and Rheumatism. 362-362. 1996
- Assessment of antibody formation in patients with osteoporosis treated with cyclical hPTH 1-34 and salmon calcitonin.. Journal of Bone and Mineral Research. T623-T623. 1996
- Comparison of etidronate and estrogen: Effects on lumbar spinal bone mineral density change and vertebral fracture rate.. Journal of Bone and Mineral Research. M652-M652. 1996
- Cyclical parathyroid hormone with or without sequential calcitonin or treat osteoporosis: Final results of a 2 year clinical trial. Journal of Bone and Mineral Research. T622-T622. 1996
- What is the yield of screening for secondary causes of osteoporosis?. Journal of Bone and Mineral Research. T643-T643. 1996
- IN-VIVO ASSESSMENT OF TRABECULAR BONE-STRUCTURE. Journal of Bone and Mineral Research. S472-S472. 1995
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP. Journal of Bone and Mineral Research. S253-S253. 1995
- WILLINGNESS TO INITIATE HORMONE REPLACEMENT THERAPY FOR PREVENTION OR TREATMENT OF OSTEOPOROSIS - IDENTIFICATION OF PATIENT SUBSETS. Journal of Bone and Mineral Research. S252-S252. 1995
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP. Arthritis and Rheumatism. R34-R34. 1995
- INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS. Arthritis and Rheumatism. S51-S51. 1993
- PULSE GLUCOCORTICOSTEROID (GCS) THERAPY IN RA PATIENTS INHIBITS WHOLE-BLOOD LEUKOTRIENE B4(LTB4) BIOSYNTHESIS EX-VIVO. Arthritis and Rheumatism. S269-S269. 1993
- VITAMIN-D AND CALCIUM IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS - FOLLOW-UP OVER 3 YEARS. Arthritis and Rheumatism. S51-S51. 1993
- VITAMIN-D DEFICIENCY IS COMMON IN ELDERLY OSTEOPOROTIC PATIENTS. Arthritis and Rheumatism. S121-S121. 1993
- INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS. Journal of Bone and Mineral Research. S325-S325. 1993
- PULSE GLUCOCORTICOSTEROID (GCS) THERAPY IN RA PATIENTS INHIBITS WHOLE-BLOOD LEUKOTRIENE-B4 (LTB4) BIOSYNTHESIS EXVIVO. Arthritis and Rheumatism. R35-R35. 1993
- SCREENING-TESTS HAVE A HIGH-YIELD IN ELDERLY OSTEOPOROTIC PATIENTS. Arthritis and Rheumatism. R40-R40. 1993
- NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS. Arthritis and Rheumatism. S120-S120. 1992
- NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS. Journal of Bone and Mineral Research. S193-S193. 1992
- DEVELOPMENT OF A QUESTIONNAIRE TO ASSESS QUALITY-OF-LIFE IN WOMEN WITH VERTEBRAL FRACTURES DUE TO OSTEOPOROSIS. Clinical Research. A371-A371. 1992
- FLUORIDE (F) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA). Clinical and Investigative Medicine. B123-B123. 1987
- VITAMIN-D AND CALCIUM IN THE PREVENTION OF CORTICOSTEROID (CS) INDUCED OSTEOPOROSIS. Clinical and Investigative Medicine. B124-B124. 1987
journal articles
- Mapping context of sedentary behaviour in older adults who are prefrail and frail: an analysis of secondary outcomes from a longitudinal study (MAPS-B).. BMJ Open. 14:e084610. 2024
- Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.. Osteoporosis International. 1-10. 2024
- Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk. Osteoporosis International. 35:1487-1496. 2024
- Physicians’ knowledge, attitudes, and practices regarding fibromyalgia: A systematic review and meta-analysis of cross-sectional studies. Medicine (United States). 103:e39109-e39109. 2024
- Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study. Archives of Osteoporosis. 19:53. 2024
- Exploring the perspectives of older adults who are pre-frail and frail to identify interventions to reduce sedentary behaviour and improve mobility: a thematic content analysis. BMC International Health and Human Rights. 24:1582. 2024
- Sedentary behavior does not predict low BMD nor fracture—population-based Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research. 39:231-240. 2024
- Opportunistic Screening of Low Bone Mineral Density From Standard X-Rays. Journal of the American College of Radiology. 21:633-639. 2024
- Postfracture survival in a population-based study of adults aged ≥66 yr: a call to action at hospital discharge. JBMR Plus. 8:ziae002. 2024
- Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study. Osteoporosis International. 35:451-468. 2024
- Automatic Radar-Based Step Length Measurement in the Home for Older Adults Living with Frailty. Sensors. 24:1056-1056. 2024
- A CNN-based strategy to automate contour detection of the hip and proximal femur using DXA hip images from longitudinal databases (CLSA and CaMos). Computer Methods in Biomechanics and Biomedical Engineering: Imaging and Visualization. 11. 2024
- Assessing the feasibility of an integrated collection of education modules for fall and fracture prevention (iCARE) for healthcare providers in long term care: A longitudinal study.. PLOS Global Public Health. 4:e0003096. 2024
- Mapping sedentary behaviour (MAPS-B) in winter and spring using wearable sensors, indoor positioning systems, and diaries in older adults who are pre-frail and frail: A feasibility longitudinal study. PLoS ONE. 19:e0290197-e0290197. 2024
- Risk Factors and Clinical Outcomes Associated With Sarcopenia in Rheumatoid Arthritis. Journal of Clinical Rheumatology. 30:18-25. 2024
- The effect of femur positioning on dual-energy X-ray absorptiometry (DXA) measures and statistical shape and appearance modeling (SSAM) fracture risk assessments. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine. 238:90-98. 2024
- The Geras virtual frailty rehabilitation program to build resilience in older adults with frailty during COVID-19: a randomized feasibility trial. Pilot and Feasibility Studies. 9:124. 2023
- Exploring participant attrition in a longitudinal follow-up of older adults: the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort. BMJ Open. 13:e066594-e066594. 2023
- Performance of methods for analyzing continuous data from stratified cluster randomized trials – A simulation study. Contemporary Clinical Trials Communications. 33:101115-101115. 2023
- Effect of Vitamin D₃ Supplementation on Acute Fracture Healing: A Phase II Screening Randomized Double‐Blind Controlled Trial. JBMR Plus. 7:e10705. 2023
- Trends in risk factor control in patients with gout: data from the National Health and Nutrition Examination Survey, 2007–2018. Rheumatology. 62:158-168. 2022
- An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA). Archives of Osteoporosis. 17:31. 2022
- Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout. Cardiovascular Diabetology. 21:133. 2022
- Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group. Archives of Osteoporosis. 17:87. 2022
- The reporting and handling of missing data in longitudinal studies of older adults is suboptimal: a methodological survey of geriatric journals. BMC Medical Research Methodology. 22:122. 2022
- Association Among Cognition, Frailty, and Falls and Self‐Reported Incident Fractures: Results From the Canadian Longitudinal Study on Aging (CLSA). JBMR Plus. 6:e10679. 2022
- Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022:1-14. 2022
- Relationship between Serum 25-Hydroxyvitamin D Level and Risk of Recurrent Stroke. Nutrients. 14:1908-1908. 2022
- Exploring the Association between Pain and Fracture Characteristics in Women with Osteoporotic Vertebral Fractures. Physiotherapy Canada. Physiotherapie Canada. 74:165-172. 2022
- The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids. Arthritis & Rheumatology. 74:604-611. 2022
- Birth Weight and the Risk of Cardiovascular Outcomes: A Report From the Large Population-Based UK Biobank Cohort Study. Frontiers in Cardiovascular Medicine. 9:827491. 2022
- Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients. Osteoporosis International. 33:113-122. 2022
- Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario. BMC Musculoskeletal Disorders. 22:105. 2021
- Response to Letter from Prof Aspen, re. "Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans". Osteoporosis International. 32:2595-2595. 2021
- Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research. 36:2106-2115. 2021
- Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis. Osteoporosis International. 32:1713-1723. 2021
- Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada. Osteoporosis International. 32:1753-1761. 2021
- Developing a Fracture Risk Clinical Assessment Protocol for Long-Term Care: A Modified Delphi Consensus Process. Journal of the American Medical Directors Association. 22:1726-1734.e8. 2021
- Management of social isolation and loneliness in community-dwelling older adults: protocol for a network meta-analysis of randomised controlled trials. BMJ Open. 11:e042828-e042828. 2021
- Factors That Predict 1-Year Incident Hip and Non-Hip Fractures for Home Care Recipients: A Linked-Data Retrospective Cohort Study. Journal of the American Medical Directors Association. 22:1035-1042. 2021
- Validation of the Fracture Risk Scale Home Care (FRS-HC) Across 4 Canadian Provinces. Journal of the American Medical Directors Association. 22:1114-1116. 2021
- Exploring Fear of Falling and Exercise Self-Efficacy in Older Women With Vertebral Fractures. Journal of Aging and Physical Activity. 29:219-224. 2021
- Exploring changes in bone mass in individuals with a chronic spinal cord injury. Osteoporosis International. 32:759-767. 2021
- Identifying Patients with Osteoarthritis at Risk of Sarcopenia using the SARC-F. Canadian Geriatrics Journal. 24:1-7. 2021
- Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada. BMC Musculoskeletal Disorders. 22:224. 2021
- Therapies for Preventing Bone Loss with Glucocorticoid Treatment. Current Osteoporosis Reports. 19:34-39. 2021
- Vertebral Fractures: Which Radiological Criteria Are Better Associated With the Clinical Course of Osteoporosis?. Canadian Association of Radiologists Journal. 72:150-158. 2021
- A scorecard for osteoporosis in Canada and seven Canadian provinces. Osteoporosis International. 32:123-132. 2021
- Preventing Fractures in Long-Term Care: Translating Recommendations to Clinical Practice. Journal of the American Medical Directors Association. 22:36-42. 2021
- Understanding and Managing Corticosteroid-Induced Osteoporosis. Open Access Rheumatology: Research and Reviews. Volume 13:177-190. 2021
- A Risk Assessment Tool for Predicting Fragility Fractures and Mortality in the Elderly. Journal of Bone and Mineral Research. 35:1923-1934. 2020
- Analysis and reporting of stratified cluster randomized trials—a systematic survey. Trials. 21:930. 2020
- Bone Marrow and Muscle Fat Infiltration Are Correlated among Postmenopausal Women With Osteoporosis: The AMBERS Cohort Study. Journal of Bone and Mineral Research. 35:516-527. 2020
- Combining Frailty and Trabecular Bone Score Did Not Improve Predictive Accuracy in Risk of Major Osteoporotic Fractures. Journal of Bone and Mineral Research. 35:1058-1064. 2020
- Differences in fracture prevalence and in bone mineral density between Chinese and White Canadians: the Canadian Multicentre Osteoporosis Study (CaMos). Archives of Osteoporosis. 15:147. 2020
- Relationship Between Obesity and Risk of Major Osteoporotic Fracture in Postmenopausal Women: Taking Frailty Into Consideration. Journal of Bone and Mineral Research. 35:2355-2362. 2020
- Reply to: The Association Between Cognitive Decline and Bone Loss and Fracture Risk Is Not Affected by Medication With Anticholinergic Effect. Journal of Bone and Mineral Research. 37:1075-1076. 2020
- The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial. Journal of Bone and Mineral Research. 37:2435-2442. 2020
- A Valid and Precise Semiautomated Method for Quantifying Intermuscular Fat Intramuscular Fat in Lower Leg Magnetic Resonance Images. Journal of Clinical Densitometry. 23:611-622. 2020
- Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans. Osteoporosis International. 31:1925-1933. 2020
- Association between frailty and risk of fall among diabetic patients. Endocrine Connections. 9:1057-1064. 2020
- Change in Quantitative Ultrasound-assessed Speed of Sound as a Function of Age in Women and Men and Association With the Use of Antiresorptive Agents: The Canadian Multicentre Osteoporosis Study. Journal of Clinical Densitometry. 23:549-560. 2020
- Promoting Osteoporosis Best Practices: A New Electronic Medical Record Tool. Journal of the American Medical Directors Association. 21:1349-1352. 2020
- Romosozumab in the Treatment of Osteoporosis. Immunotherapy. 12:965-981. 2020
- Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot Trial. Osteoporosis International. 31:1115-1123. 2020
- Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis Study. Osteoporosis International. 31:1145-1153. 2020
- Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients. Osteoporosis International. 31:973-980. 2020
- Correction to: Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients. Osteoporosis International. 31:981-981. 2020
- The Effects of Home Exercise in Older Women With Vertebral Fractures: A Pilot Randomized Controlled Trial. Physical Therapy. 100:662-676. 2020
- Evaluation of the Fracture Liaison Service within the Canadian Healthcare Setting. Journal of Osteoporosis. 2020:1-6. 2020
- An empirical comparison of methods for analyzing over-dispersed zero-inflated count data from stratified cluster randomized trials. Contemporary Clinical Trials Communications. 17:100539-100539. 2020
- A Higher Proportion of Home Care Recipients Experience Nonhip Fractures Than Long-Term Care Residents. Journal of the American Medical Directors Association. 21:289-290. 2020
- Are osteoporotic vertebral fractures or forward head posture associated with performance-based measures of balance and mobility?. Archives of Osteoporosis. 14:67. 2019
- Determining known-group validity and test-retest reliability in the PEQ (personalized exercise questionnaire). BMC Musculoskeletal Disorders. 20:373. 2019
- Exploring the association between number, severity, location of fracture, and occiput-to-wall distance. Archives of Osteoporosis. 14:27. 2019
- Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos). Archives of Osteoporosis. 14:53. 2019
- Study protocol: design and rationale for an exploratory phase II randomized controlled trial to determine optimal vitamin D3 supplementation strategies for acute fracture healing. Pilot and Feasibility Studies. 5:135. 2019
- Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis. Journal of Bone and Mineral Research. 34:2001-2011. 2019
- Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Best Practices Research Initiative. Bone. 127:129-134. 2019
- Management of Frailty: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Journal of the American Medical Directors Association. 20:1190-1198. 2019
- The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study. JBMR Plus. 3:e10211. 2019
- Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study. Osteoporosis International. 30:1635-1644. 2019
- Glucocorticoid induced osteoporosis. Expert Review of Endocrinology and Metabolism. 14:259-266. 2019
- Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial. Arthritis & Rheumatology. 71:1174-1184. 2019
- Score Distributions of the Balance Outcome Measure for Elder Rehabilitation (BOOMER) in Community-Dwelling Older Adults With Vertebral Fracture. Journal of Geriatric Physical Therapy. 42:E87-E93. 2019
- Inter-rater reliability of Dartfish^TM movement analysis software for measuring maximum flexion and extension at the hip and knee in older adults with osteoporosis and osteopenia. Psychological Medicine. 35:577-585. 2019
- Incident Fragility Fractures Have a Long-Term Negative Impact on Health-Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research. 34:838-848. 2019
- Frailty and Risk of Fractures in Patients With Type 2 Diabetes. Diabetes Care. 42:507-513. 2019
- Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study. Osteoporosis International. 30:817-828. 2019
- 236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1–3 June 2018. Neuromuscular Disorders. 29:251-259. 2019
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study. Journal of Bone and Mineral Research. 34:419-428. 2019
- Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. The Lancet Diabetes and Endocrinology. 7:34-43. 2019
- Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation. Osteoporosis International. 30:45-57. 2019
- A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research. BMC Medical Research Methodology. 18:9. 2018
- Getting fit for hip and knee replacement: a protocol for the Fit-Joints pilot randomized controlled trial of a multi-modal intervention in frail patients with osteoarthritis. Pilot and Feasibility Studies. 4:127. 2018
- Osteoporotic fractures and obesity affect frailty progression: a longitudinal analysis of the Canadian multicentre osteoporosis study. BMC Geriatrics. 18:4. 2018
- Validation of a one year fracture prediction tool for absolute hip fracture risk in long term care residents. BMC Geriatrics. 18:320. 2018
- Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture. Osteoporosis International. 29:2545-2556. 2018
- Attitudes Toward and Management of Fibromyalgia. Journal of Clinical Rheumatology. 24:243-249. 2018
- Vertebral Fractures and Morphometric Deformities. Journal of Bone and Mineral Research. 33:1544-1545. 2018
- A Systematic Survey of Control Groups in Behavioral and Social Science Trials. Research on Social Work Practice. 28:538-545. 2018
- Does Muscle Atrophy and Fatty Infiltration Plateau or Persist in Chronic Spinal Cord Injury?. Journal of Clinical Densitometry. 21:329-337. 2018
- Evaluating Completeness of Reporting in Behavioral Interventions Pilot Trials. Research on Social Work Practice. 28:577-584. 2018
- Combined hormonal contraceptives use and bone mineral density changes in adolescent and young women in a prospective population-based Canada-wide observational study.. Journal of Musculoskeletal Neuronal Interactions. 18:227-236. 2018
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. The Lancet Diabetes and Endocrinology. 6:445-454. 2018
- Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos). Journal of Bone and Mineral Research. 33:569-579. 2018
- Measuring Marrow Density and Area Using Peripheral Quantitative Computed Tomography at the Tibia: Precision in Young and Older Adults and Individuals With Spinal Cord Injury. Journal of Clinical Densitometry. 21:269-280. 2018
- Patient preferences for nutritional supplementation to improve fracture healing: a discrete choice experiment. BMJ Open. 8:e019685-e019685. 2018
- Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses. Journal of Bone and Mineral Research. 33:419-429. 2018
- Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings. Acta Paediatrica, International Journal of Paediatrics. 107:534-537. 2018
- The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study. Osteoporosis International. 29:329-337. 2018
- Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? – A systematic review of reviews: an update. Journal of Multidisciplinary Healthcare. Volume 11:495-510. 2018
- Efficacy of a biomechanically-based yoga exercise program in knee osteoarthritis: A randomized controlled trial. PLoS ONE. 13:e0195653-e0195653. 2018
- Enhancing research publications and advancing scientific writing in health research collaborations: sharing lessons learnt from the trenches. Journal of Multidisciplinary Healthcare. Volume 11:245-254. 2018
- Investigating the Effects of Motion Streaks on pQCT-Derived Leg Muscle Density and Its Association With Fractures. Journal of Clinical Densitometry. 21:130-139. 2018
- Corrigendum to “The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer”. Journal of Oncology. 2017:1-1. 2017
- A Missed Opportunity in Bone Health: Vitamin D and Calcium Use in Elderly Femoral Neck Fracture Patients Following Arthroplasty. Geriatric Orthopaedic Surgery and Rehabilitation. 8:215-224. 2017
- A scoping review of comparisons between abstracts and full reports in primary biomedical research. BMC Medical Research Methodology. 17:181. 2017
- An overview of osteoporosis and frailty in the elderly. BMC Musculoskeletal Disorders. 18:46. 2017
- Development and validation of a new tool to measure the facilitators, barriers and preferences to exercise in people with osteoporosis. BMC Musculoskeletal Disorders. 18:540. 2017
- Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study. BMC Musculoskeletal Disorders. 18:174. 2017
- Management of frailty: a protocol of a network meta-analysis of randomized controlled trials. Systematic Reviews. 6:130. 2017
- Self-perception of fracture risk: what can it tell us?. Osteoporosis International. 28:3495-3500. 2017
- Spine bone mineral density increases after 6 months of exclusive lactation, even in women who keep breastfeeding. Archives of Osteoporosis. 12:73. 2017
- Agreement between fragility fracture risk assessment algorithms as applied to adults with chronic spinal cord injury. Spinal Cord. 55:985-993. 2017
- Baseline knee adduction moment interacts with body mass index to predict loss of medial tibial cartilage volume over 2.5 years in knee Osteoarthritis. Journal of Orthopaedic Research. 35:2476-2483. 2017
- Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS). Osteoporosis International. 28:2867-2876. 2017
- Development and validation of the Fracture Risk Scale (FRS) that predicts fracture over a 1-year time period in institutionalised frail older people living in Canada: an electronic record-linked longitudinal cohort study. BMJ Open. 7:e016477-e016477. 2017
- Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization.. Journal of Musculoskeletal Neuronal Interactions. 17:146-154. 2017
- Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality. Journal of Bone and Mineral Research. 32:1802-1810. 2017
- Regional Differences in Incident Prefrailty and Frailty. Journal of Women's Health. 26:992-998. 2017
- The effect of bariatric surgery on serum 25-OH vitamin D levels: a systematic review and meta-analysis. Obesity Science and Practice. 3:319-332. 2017
- Corrigendum to “Risk Factors for Fracture in Diabetes: The Canadian Multicentre Osteoporosis Study”. ISRN Dentistry. 2017:1-1. 2017
- Modifying the Phenotypic Frailty Model in Predicting Risk of Major Osteoporotic Fracture in the Elderly. Journal of the American Medical Directors Association. 18:414-419. 2017
- Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study. BMC Musculoskeletal Disorders. 18. 2017
- Muscle and Myotendinous Tissue Properties at the Distal Tibia as Assessed by High-Resolution Peripheral Quantitative Computed Tomography. Journal of Clinical Densitometry. 20:226-232. 2017
- Relationships between fatty infiltration in the thigh and calf in women with knee osteoarthritis. Aging - Clinical and Experimental Research. 29:291-299. 2017
- Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review. Osteoporosis International. 28:735-745. 2017
- State of reporting of primary biomedical research: a scoping review protocol. BMJ Open. 7:e014749-e014749. 2017
- Biologic therapies and bone loss in rheumatoid arthritis. Osteoporosis International. 28:429-446. 2017
- Lean muscle volume of the thigh has a stronger relationship with muscle power than muscle strength in women with knee osteoarthritis. Clinical Biomechanics. 41:92-97. 2017
- Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis. Clinical and Experimental Rheumatology. 35:S56-S60. 2017
- Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.. Clinical and Experimental Rheumatology. 35 Suppl 106:56-60. 2017
- Loss of health related quality of life following low-trauma fractures in the elderly. BMC Geriatrics. 16:84. 2016
- Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function. American Society of Nephrology. Clinical Journal. 11:2032-2040. 2016
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 375:1532-1543. 2016
- The current economic burden of illness of osteoporosis in Canada. Osteoporosis International. 27:3023-3032. 2016
- A Comparison of CAROC and FRAX in Patients with Fragility Fracture. Journal of Rheumatology. 43:1456-1457. 2016
- Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women. Journal of Bone and Mineral Research. 31:1466-1472. 2016
- Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis. Osteoporosis International. 27:1989-1998. 2016
- Osteoporosis guideline implementation in family medicine using electronic medical records Survey of learning needs and barriers. Canadian Family Physician. 62:E326-E333. 2016
- Quantifying fat and lean muscle in the lower legs of women with knee osteoarthritis using two different MRI systems. Rheumatology International. 36:855-862. 2016
- Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporosis International. 27:1709-1718. 2016
- Comparison of Speed of Sound Measures Assessed by Multisite Quantitative Ultrasound to Bone Mineral Density Measures Assessed by Dual-Energy X-Ray Absorptiometry in a Large Canadian Cohort: the Canadian Multicentre Osteoporosis Study (CaMos). Journal of Clinical Densitometry. 19:234-241. 2016
- Dietary patterns in men and women are simultaneously determinants of altered glucose metabolism and bone metabolism. Progress in Food and Nutrition Science. 36:328-336. 2016
- Frailty Change and Major Osteoporotic Fracture in the Elderly: Data from the Global Longitudinal Study of Osteoporosis in Women 3-Year Hamilton Cohort. Journal of Bone and Mineral Research. 31:718-724. 2016
- The reliability of a segmentation methodology for assessing intramuscular adipose tissue and other soft-tissue compartments of lower leg MRI images. Magnetic Resonance Materials in Physics, Biology, and Medicine. 29:237-244. 2016
- Sclerostin: More than a bone formation brake. Science Translational Medicine. 8:330fs7. 2016
- Bisphosphonate drug holidays: we reap what we sow. Osteoporosis International. 27:849-852. 2016
- Comparative trends in incident fracture rates for all long-term care and community-dwelling seniors in Ontario, Canada, 2002–2012. Osteoporosis International. 27:887-897. 2016
- Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study. Osteoporosis International. 27:1227-1238. 2016
- Intermittent and constant pain and physical function or performance in men and women with knee osteoarthritis: data from the osteoarthritis initiative. Clinical Rheumatology. 35:371-379. 2016
- Fracture Incidence in Adult Kidney Transplant Recipients. Transplantation. 100:167-175. 2016
- Frequency of Bone Mineral Density Testing in Adult Kidney Transplant Recipients from Ontario, Canada: A Population-Based Cohort Study. Canadian Journal of Kidney Health and Disease. 3:92-92. 2016
- Risk factors for fracture in adult kidney transplant recipients. World Journal of Transplantation. 6:370-370. 2016
- The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review. Journal of Osteoporosis. 2016:1-5. 2016
- Do Knee Moments Normalized to Measures of Knee Cartilage Area Better Classify the Severity of Knee Osteoarthritis?. Journal of Applied Biomechanics. 31:415-422. 2015
- Estimating osteoporotic fracture risk following a wrist fracture: a tale of two systems. Archives of Osteoporosis. 10:13. 2015
- Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporosis International. 26:2763-2771. 2015
- Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial. Trials. 16:214. 2015
- Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis. Climacteric. 18:805-812. 2015
- Bilateral atypical femoral fractures: how much symmetry is there on imaging?. Skeletal Radiology. 44:1579-1584. 2015
- Muscle Density and Bone Quality of the Distal Lower Extremity Among Individuals with Chronic Spinal Cord Injury. Topics in Spinal Cord Injury Rehabilitation. 21:282-293. 2015
- Recommandations en vue de la prévention des fractures dans les établissements de soins de longue durée. CANADIAN MEDICAL ASSOCIATION JOURNAL. 187:E450-E461. 2015
- Recommendations for preventing fracture in long term care. CANADIAN MEDICAL ASSOCIATION JOURNAL. 187:E450-E461. 2015
- Recommendations for preventing fracture in long-term care. CANADIAN MEDICAL ASSOCIATION JOURNAL. 187:1135-1144. 2015
- Associations of protein intake and protein source with bone mineral density and fracture risk: A population-based cohort study. Journal of Nutrition, Health and Aging. 19:861-868. 2015
- Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women. Bone. 79:58-64. 2015
- Fat Infiltration in the Leg is Associated with Bone Geometry and Physical Function in Healthy Older Women. Calcified Tissue International. 97:353-363. 2015
- Assessing the Reliability of a Semiautomated Segmentation Algorithm for Quantifying Erosions in the Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis. Journal of Rheumatology. 42:1582-1586. 2015
- Knee adduction moment relates to medial femoral and tibial cartilage morphology in clinical knee osteoarthritis. Journal of Biomechanics. 48:3495-3501. 2015
- Comparison between frailty index of deficit accumulation and fracture risk assessment tool (FRAX) in prediction of risk of fractures. Bone. 77:107-114. 2015
- The relationship between long-term proton pump inhibitor therapy and skeletal frailty. Endocrine. 49:606-610. 2015
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program. Current Medical Research and Opinion. 31:1391-1401. 2015
- A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part III: SD, SEE, LSC Association With Fragility Fractures. Journal of Clinical Densitometry. 18:408-418. 2015
- Development of a Skeletal Muscle Mimic Phantom Compatible with QCT and MR Imaging. Journal of Medical Imaging and Radiation Sciences. 46:174-181. 2015
- Osteoporosis Prescribing in Long-Term Care: Impact of a Provincial Knowledge Translation Strategy. Canadian Journal on Aging. 34:137-148. 2015
- The Tissue-Selective Estrogen Complex: A Review of Current Evidence. Rheumatology and Therapy. 2:47-58. 2015
- A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part II: 1-Yr Change, Long-Term Precision, and Least Significant Change. Journal of Clinical Densitometry. 18:260-269. 2015
- Comparison of Fracture Risk Prediction among Individuals with Reduced and Normal Kidney Function. American Society of Nephrology. Clinical Journal. 10:646-653. 2015
- Response to the Letter to the Editor on “Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial”. Journal of Clinical Densitometry. 18:270-271. 2015
- Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clinical Endocrinology. 82:359-368. 2015
- Lower-extremity muscle atrophy and fat infiltration after chronic spinal cord injury.. Journal of Musculoskeletal Neuronal Interactions. 15:32-41. 2015
- Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study — Comparing site and age-specific risks in women and men. Bone. 71:237-243. 2015
- A Trimodality Comparison of Volumetric Bone Imaging Technologies. Part I: Short-term Precision and Validity. Journal of Clinical Densitometry. 18:124-135. 2015
- Characterizing the Assessment and Management of Vitamin D Levels in Patients with Osteoporosis in Clinical Practice: A Chart Review Initiative. Journal of Osteoporosis. 2015:1-7. 2015
- Comparison between Frailty Index of Deficit Accumulation and Phenotypic Model to Predict Risk of Falls: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton Cohort. PLoS ONE. 10:e0120144-e0120144. 2015
- Improving Reliability of pQCT-Derived Muscle Area and Density Measures Using a Watershed Algorithm for Muscle and Fat Segmentation. Journal of Clinical Densitometry. 18:93-101. 2015
- International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study. Osteoporosis International. 26:419-420. 2015
- Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.. Clinical and Experimental Rheumatology. 33:537-544. 2015
- The Relationship between Intramuscular Adipose Tissue, Functional Mobility, and Strength in Postmenopausal Women with and without Type 2 Diabetes. Journal of Aging Research. 2015:1-9. 2015
- A Frailty Index predicts 10-year fracture risk in adults age 25 years and older: results from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporosis International. 25:2825-2832. 2014
- A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial. Trials. 15:268. 2014
- Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study. BMC Musculoskeletal Disorders. 15:201. 2014
- Frailty index of deficit accumulation and falls: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort. BMC Musculoskeletal Disorders. 15:185. 2014
- Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos). Archives of Osteoporosis. 9:169. 2014
- Implementing a Knowledge Translation Intervention in Long-Term Care: Feasibility Results From the Vitamin D and Osteoporosis Study (ViDOS). Journal of the American Medical Directors Association. 15:943-945. 2014
- Peripheral quantitative computed tomography-derived muscle density and peripheral magnetic resonance imaging-derived muscle adiposity: precision and associations with fragility fractures in women.. Journal of Musculoskeletal Neuronal Interactions. 14:401-410. 2014
- Prospectively measured 10-year changes in health-related quality of life and comparison with cross-sectional estimates in a population-based cohort of adult women and men. Quality of Life Research. 23:2707-2721. 2014
- Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture. Journal of Bone and Mineral Research. 29:2545-2551. 2014
- Worldwide uptake of FRAX. Archives of Osteoporosis. 9:166. 2014
- Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus. 23:1156-1163. 2014
- Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial. Journal of Clinical Densitometry. 17:458-465. 2014
- Normative Data for Multisite Quantitative Ultrasound: The Canadian Multicenter Osteoporosis Study. Journal of Clinical Densitometry. 17:534-540. 2014
- Systemic Lupus Erythematosus, Osteoporosis, and Fractures. Journal of Rheumatology. 41:1913-1915. 2014
- The three-year incidence of fracture in chronic kidney disease. Kidney International. 86:810-818. 2014
- Build Better Bones With Exercise: Protocol for a Feasibility Study of a Multicenter Randomized Controlled Trial of 12 Months of Home Exercise in Women With a Vertebral Fracture. Physical Therapy. 94:1337-1352. 2014
- Effect of Odanacatib on BMD and Fractures: Estimates from Bayesian Univariate and Bivariate Meta-analyses. Journal of Clinical Endocrinology and Metabolism (JCEM). 99:3070-3079. 2014
- Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period. Annals of Pharmacotherapy. 48:954-961. 2014
- Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporosis International. 25:1473-1481. 2014
- Knee Power Is an Important Parameter in Understanding Medial Knee Joint Load in Knee Osteoarthritis. Arthritis Care and Research. 66:687-694. 2014
- Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.. Canadian Family Physician. 60:324-333. 2014
- Efficacy of Vitamin D Supplementation in Depression in Adults: A Systematic Review. Journal of Clinical Endocrinology and Metabolism (JCEM). 99:757-767. 2014
- Empirically Based Composite Fracture Prediction Model From the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). Journal of Clinical Endocrinology and Metabolism (JCEM). 99:817-826. 2014
- Inclinometer-based measures of standing posture in older adults with low bone mass are reliable and associated with self-reported, but not performance-based, physical function. Osteoporosis International. 25:721-728. 2014
- Obesity, Health-Care Utilization, and Health-Related Quality of Life After Fracture in Postmenopausal Women: Global Longitudinal Study of Osteoporosis in Women (GLOW). Calcified Tissue International. 94:223-231. 2014
- Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW). Journal of Bone and Mineral Research. 29:487-493. 2014
- Differences inIn VitroDisintegration Time among Canadian Brand and Generic Bisphosphonates. Journal of Osteoporosis. 2014:1-6. 2014
- Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporosis International. 25:85-95. 2014
- Exploring the determinants of fracture risk among individuals with spinal cord injury. Osteoporosis International. 25:177-185. 2014
- Heterogeneity in Skeletal Load Adaptation Points to a Role for Modeling in the Pathogenesis of Osteoporotic Fracture. Journal of Clinical Densitometry. 17:170-176. 2014
- Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW). Journal of Bone and Mineral Research. 29:260-267. 2014
- A critical review of brand and generic alendronate for the treatment of osteoporosis. SpringerPlus. 2:550. 2013
- Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study. BMC Musculoskeletal Disorders. 14:114. 2013
- Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Systematic Reviews. 2:64. 2013
- The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study. BMC Musculoskeletal Disorders. 14:253. 2013
- Human parathyroid hormone for the treatment of osteoporosis in post-menopausal women. Clinical Respiratory Journal. 2013. 2013
- Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporosis International. 24:2763-2764. 2013
- Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: Insight into the BMD and bone fragility paradox. Metabolism: Clinical and Experimental. 62:1401-1405. 2013
- Fracture risk prediction: importance of age, BMD and spine fracture status. BoneKEy Reports. 2:404. 2013
- Multisite quantitative ultrasound for the prediction of fractures over 5 years of follow-up: The Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research. 28:2027-2034. 2013
- Calcium and Vitamin D Intake and Mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos). Journal of Clinical Endocrinology and Metabolism (JCEM). 98:3010-3018. 2013
- An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Annals of the Rheumatic Diseases. 72:911-917. 2013
- High-Resolution Peripheral Quantitative Computed Tomography for the Assessment of Bone Strength and Structure: A Review by the Canadian Bone Strength Working Group. Current Osteoporosis Reports. 11:136-146. 2013
- How to define responders in osteoarthritis. Current Medical Research and Opinion. 29:719-729. 2013
- Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone. 54:76-82. 2013
- The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporosis International. 24:1161-1168. 2013
- Adapting the Iconic Pain Assessment Tool Version 2 (IPAT2) for Adults and Adolescents With Arthritis Pain Through Usability Testing and Refinement of Pain Quality Icons. Clinical Journal of Pain. 29:253-264. 2013
- Frailty and Fracture, Disability, and Falls: A Multiple Country Study From the Global Longitudinal Study of Osteoporosis in Women. Journal of The American Geriatrics Society. 61:327-334. 2013
- Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis. Osteoporosis International. 24:581-593. 2013
- Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis. Menopause. 20:130-137. 2013
- Accumulation of bone strontium measured by in vivo XRF in rats supplemented with strontium citrate and strontium ranelate. Bone. 52:63-69. 2013
- Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporosis International. 24:59-67. 2013
- Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS ONE. 8:e82840-e82840. 2013
- When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW). PLoS ONE. 8:e83306-e83306. 2013
- Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing. Journal of Bone and Joint Surgery. American volume. 94:2113-2119. 2012
- An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Archives of Osteoporosis. 7:25-30. 2012
- An interdisciplinary knowledge translation intervention in long-term care: Study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial. Implementation Science. 7:48. 2012
- Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women. Osteoporosis International. 23:2863-2871. 2012
- Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone. 51:975-980. 2012
- Denosumab: mechanism of action and clinical outcomes. International Journal of Clinical Practice. 66:1139-1146. 2012
- Leisure-Time Physical Activity and Perceived Health in People Living with Osteoporosis. Applied Research in Quality of Life. 7:391-402. 2012
- Treatment failure in osteoporosis. Osteoporosis International. 23:2769-2774. 2012
- Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada. Journal of Medical Economics. 15:3-14. 2012
- The burden of illness of osteoporosis in Canada. Osteoporosis International. 23:2591-2600. 2012
- Management of Glucocorticoid-Induced Osteoporosis. Calcified Tissue International. 91:225-243. 2012
- The Authors Respond. Archives of Physical Medicine and Rehabilitation. 93:1882-1882. 2012
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporosis International. 23:2257-2276. 2012
- Antidepressant medications and osteoporosis. Bone. 51:606-613. 2012
- Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women. Osteoporosis International. 23:2179-2188. 2012
- The burden of illness of osteoporosis in Canadian men. Journal of Bone and Mineral Research. 27:1830-1838. 2012
- Frailty and sarcopenia: definitions and outcome parameters. Osteoporosis International. 23:1839-1848. 2012
- Monitoring bone strontium levels of an osteoporotic subject due to self-administration of strontium citrate with a novel diagnostic tool, in vivo XRF: A case study. Bone. 51:93-97. 2012
- The Relationship between Radial Bone Properties and Disease Activity and Physical Function in Individuals with Rheumatoid Arthritis. Physiotherapy Canada. Physiotherapie Canada. 64:284-291. 2012
- Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 50:1288-1293. 2012
- Fracture Risk in Living Kidney Donors: A Matched Cohort Study. American Journal of Kidney Diseases. 59:770-776. 2012
- Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. Journal of Bone and Mineral Research. 27:1381-1389. 2012
- Predicting fracture using 2D finite element modelling. Medical Engineering and Physics. 34:478-484. 2012
- Ankle fractures do not predict osteoporotic fractures in women with or without diabetes. Osteoporosis International. 23:957-962. 2012
- Estimation of the lifetime risk of hip fracture for women and men in Canada. Osteoporosis International. 23:921-927. 2012
- Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women. Journal of Bone and Mineral Research. 27:645-653. 2012
- Volume measurement of bone erosions in magnetic resonance images of patients with rheumatoid arthritis. Magnetic Resonance in Medicine. 67:814-823. 2012
- A reappraisal of generic bisphosphonates in osteoporosis. Osteoporosis International. 23:213-221. 2012
- Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls. Arthritis Care and Research. 64:83-91. 2012
- Effect of Low-Intensity Pulsed Ultrasound on the Cartilage Repair in People With Mild to Moderate Knee Osteoarthritis: A Double-Blinded, Randomized, Placebo-Controlled Pilot Study. Archives of Physical Medicine and Rehabilitation. 93:35-42. 2012
- Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence. Journal of Bone and Mineral Research. 27:202-210. 2012
- Measurement equivalence of the SF-36 in the canadian multicentre osteoporosis study. Health and Quality of Life Outcomes. 10:29-29. 2012
- Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporosis International. 23:351-363. 2012
- The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer. Journal of Oncology. 2012:1-7. 2012
- A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: No advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders. 12:135. 2011
- Atypical Femoral Fractures in Patients Taking Longterm Alendronate. Journal of Rheumatology. 38:2686-2687. 2011
- Psychological Needs as Mediators? The Relationship Between Leisure-Time Physical Activity and Well Being in People Diagnosed With Osteoporosis. Research Quarterly for Exercise and Sport. 82:794-798. 2011
- Subtrochanteric Fractures in Bisphosphonate-Naive Patients: Results from the HORIZON-Recurrent Fracture Trial. Calcified Tissue International. 89:427-433. 2011
- Surgical preferences of patients at risk of hip fractures: hemiarthroplasty versus total hip arthroplasty. BMC Musculoskeletal Disorders. 12:289. 2011
- The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskeletal Disorders. 12:209. 2011
- Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW. American Journal of Medicine. 124:1043-1050. 2011
- Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture. Journal of The American Geriatrics Society. 59:2084-2090. 2011
- Predicting fractures in an international cohort using risk factor algorithms without BMD. Journal of Bone and Mineral Research. 26:2770-2777. 2011
- Clinical Risk Factors for Fracture in Diabetes: A Matched Cohort Analysis. Journal of Clinical Densitometry. 14:416-421. 2011
- In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada. Current Medical Research and Opinion. 27:1749-1754. 2011
- A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: The IVORY trial. Contemporary Clinical Trials. 32:741-746. 2011
- Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 49:493-498. 2011
- The burden of osteoporotic fractures beyond acute care: the Canadian Multicentre Osteoporosis Study (CaMos). Age and Ageing. 40:602-607. 2011
- Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial. Osteoporosis International. 22:2539-2549. 2011
- Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporosis International. 22:2329-2336. 2011
- Reproducibility of Peripheral Quantitative Computed Tomography Measurements at the Radius and Tibia in Healthy Pre- and Postmenopausal Women. Canadian Association of Radiologists Journal. 62:183-189. 2011
- FRAX® Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference. Journal of Clinical Densitometry. 14:223-225. 2011
- Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification. Journal of Clinical Densitometry. 14:226-236. 2011
- Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture. Journal of Clinical Densitometry. 14:212-219. 2011
- Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporosis International. 22:1873-1883. 2011
- Health-related quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZON-PFT. Bone. 48:1298-1304. 2011
- Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk. Journal of Clinical Endocrinology and Metabolism (JCEM). 96:1727-1736. 2011
- Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study. Calcified Tissue International. 88:425-431. 2011
- Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporosis International. 22:817-827. 2011
- Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporosis International. 22:829-837. 2011
- Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporosis International. 22:789-796. 2011
- Multiplanar reconstruction recovers morphological cartilage assessment reproducibility from maloriented coronal MRI scans. Magnetic Resonance in Medicine. 65:790-795. 2011
- Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture. CANADIAN MEDICAL ASSOCIATION JOURNAL. 183:E107-E114. 2011
- Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study. Bone. 48:218-224. 2011
- Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporosis International. 22:27-35. 2011
- Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis. Therapeutics and Clinical Risk Management. 7:157-157. 2011
- If you don't take it – it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy. Therapeutics and Clinical Risk Management. 7:181-181. 2011
- Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskeletal Disorders. 11:68. 2010
- Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskeletal Disorders. 11:130. 2010
- What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention?. BMC Geriatrics. 10:73. 2010
- Case Report: Celiac Disease Masquerading As Bone Metastasis in a 29-Year-Old Woman. Journal of Clinical Oncology. 28:e623-e625. 2010
- Hip fracture prevention strategies in long-term care: a survey of Canadian physicians' opinions.. Canadian Family Physician. 56:e392-e397. 2010
- Role of teriparatide in treatment of glucocorticoid-induced osteoporosis. Therapeutics and Clinical Risk Management. Volume 6:497-503. 2010
- Combined Vertebral Fracture Assessment and Bone Mineral Density Measurement: A Patient-friendly New Tool with an Important Impact on the Canadian Risk Fracture Classification. Canadian Association of Radiologists Journal. 61:194-200. 2010
- Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study. Journal of Bone and Mineral Research. 25:2239-2250. 2010
- Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk. Menopause. 17:1010-1016. 2010
- Impact of Prevalent Fractures on Quality of Life: Baseline Results From the Global Longitudinal Study of Osteoporosis in Women. Mayo Clinic proceedings. 85:806-813. 2010
- Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. Journal of Bone and Mineral Research. 25:1948-1957. 2010
- An assessment of the level of osteoporosis knowledge in postmenopausal breast cancer patients. International Journal of Orthopaedic and Trauma Nursing. 14:150-158. 2010
- Normative Bone Mineral Density Z-Scores for Canadians Aged 16 to 24 Years: The Canadian Multicenter Osteoporosis Study. Journal of Clinical Densitometry. 13:267-276. 2010
- A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents. PLoS ONE. 5:e9515-e9515. 2010
- Dr. Adachi and Dr. Lau reply. Journal of Rheumatology. 37:676.1-676. 2010
- Osteoporosis Knowledge Among Individuals With Recent Fragility Fracture. Orthopaedic Nursing. 29:99-107. 2010
- Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA. Current Medical Research and Opinion. 26:599-604. 2010
- The Safe Functional Motion test is reliable for assessment of functional movements in individuals at risk for osteoporotic fracture. Clinical Rheumatology. 29:143-150. 2010
- Body Weight–Supported Treadmill Training for Patients With Hip Fracture: A Feasibility Study. Archives of Physical Medicine and Rehabilitation. 90:2125-2130. 2009
- Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatrics. 9:28. 2009
- Glucocorticoid-induced osteoporosis: treatment update and review. Therapeutic Advances in Musculoskeletal Disease. 1:71-85. 2009
- Injury Measurement Properties of Serum Interleukin-6 Following Lumbar Decompression Surgery. Journal of Surgical Research. 157:161-167. 2009
- The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC). BMC Medical Education. 9:54. 2009
- Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid. Patient Preference and Adherence. 3:189-189. 2009
- Health-related Quality of Life in Canadian Adolescents and Young Adults: Normative Data Using the SF-36. Canadian Journal of Public Health. 100:449-452. 2009
- Quantitative analysis of subchondral sclerosis of the tibia by bone texture parameters in knee radiographs: site-specific relationships with joint space width. Osteoarthritis and Cartilage. 17:1453-1460. 2009
- Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture. Therapeutic Advances in Musculoskeletal Disease. 1:5-11. 2009
- Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?. Osteoporosis International. 20:1785-1793. 2009
- Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CANADIAN MEDICAL ASSOCIATION JOURNAL. 181:265-271. 2009
- Repeat Low-Trauma Fractures Occur Frequently Among Men and Women Who Have Osteopenic BMD. Journal of Bone and Mineral Research. 24:1515-1522. 2009
- Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy. Journal of Rheumatology. 36:1835-1837. 2009
- Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: A 12-week, randomized, double-blind, placebo-controlled, exploratory study. Clinical Therapeutics. 31:1747-1753. 2009
- Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture. Journal of Bone and Mineral Research. 24:1308-1313. 2009
- Bone turnover markers in the management of postmenopausal osteoporosis. Clinical Biochemistry. 42:929-942. 2009
- Monitoring strontium ranelate therapy in patients with osteoporosis. Osteoporosis International. 20:1101-1106. 2009
- The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporosis International. 20:1107-1116. 2009
- Family Physicians' Personal and Practice Characteristics that Are Associated with Improved Utilization of Bone Mineral Density Testing and Osteoporosis Medication Prescribing. Population Health Management. 12:131-138. 2009
- Glucocorticoid-induced osteoporosis. Osteoporosis International. 20:239-240. 2009
- Reproducibility of computer-assisted joint alignment measurement in OA knee radiographs. Osteoarthritis and Cartilage. 17:579-585. 2009
- The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporosis International. 20:703-714. 2009
- Detection and Treatment of Sublesional Osteoporosis Among Patients with Chronic Spinal Cord Injury. Topics in Spinal Cord Injury Rehabilitation. 14:1-22. 2009
- Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporosis International. 20:507-518. 2009
- The Development of EERA: Software for Assessing Rheumatic Joint Erosions. Canadian Association of Radiologists Journal. 60:63-68. 2009
- Raloxifene use in clinical practice. Menopause. 16:413-421. 2009
- Vertebral Fracture Status and the World Health Organization Risk Factors for Predicting Osteoporotic Fracture Risk. Journal of Bone and Mineral Research. 24:495-502. 2009
- Association Between Change in BMD and Fragility Fracture in Women and Men. Journal of Bone and Mineral Research. 24:361-370. 2009
- Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporosis International. 20:291-297. 2009
- Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Education and Counseling. 74:213-220. 2009
- Bridging the Osteoporosis Quality Chasm. Journal of Bone and Mineral Research. 24:3-7. 2009
- Depressive symptomatology and fracture risk in community-dwelling older men and women. Aging - Clinical and Experimental Research. 20:585-592. 2008
- Do patients perceive a link between a fragility fracture and osteoporosis?. BMC Musculoskeletal Disorders. 9:38. 2008
- Improvement in health-related quality of life in osteoporosis patients treated with teriparatide. BMC Musculoskeletal Disorders. 9:151. 2008
- Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients. BMC Musculoskeletal Disorders. 9:125. 2008
- Minimum joint space width and tibial cartilage morphology in the knees of healthy individuals: A cross-sectional study. BMC Musculoskeletal Disorders. 9:119. 2008
- Optimizing care in osteoporosis: The Canadian quality circle project. BMC Musculoskeletal Disorders. 9:130. 2008
- Prevalence of Osteoporosis in Osteoarthritic Patients Undergoing Total Hip or Total Knee Arthroplasty. Archives of Physical Medicine and Rehabilitation. 89:2373-2374. 2008
- Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer. Journal of Clinical Oncology. 26:5465-5476. 2008
- Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial). Chest. 134:794-800. 2008
- Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate. Journal of Clinical Endocrinology and Metabolism (JCEM). 93:3785-3793. 2008
- Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone. 43:672-678. 2008
- Erratum to: “Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis”. Journal of Clinical Epidemiology. 61:854-854. 2008
- Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CANADIAN MEDICAL ASSOCIATION JOURNAL. 178:1660-1668. 2008
- Drug Insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective. Nature Reviews Rheumatology. 4:240-248. 2008
- Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis. Osteoporosis International. 19:687-697. 2008
- The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporosis International. 19:581-587. 2008
- Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.. Canadian Family Physician. 54:394-402. 2008
- Quantitative, small bore, 1 Tesla, magnetic resonance imaging of the hands of patients with rheumatoid arthritis.. Clinical and Experimental Rheumatology. 26:860-865. 2008
- Changes in body mass index in Canadians over a five-year period: Results of a prospective, population-based study. BMC International Health and Human Rights. 7:150. 2007
- The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review. BMC Musculoskeletal Disorders. 8:97. 2007
- A Possible Role of Recurrent Major Depression in Risk of Fracture—Reply. JAMA Internal Medicine. 167:2370-2370. 2007
- The association between body mass index and health-related quality of life: data from CaMos, a stratified population study. Quality of Life Research. 16:1595-1603. 2007
- Calcium and vitamin D for osteoporotic fracture prevention. Polskie Archiwum Medycyny Wewnetrznej. 117:441-442. 2007
- Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility.. Canadian Family Physician. 53:1694-1700. 2007
- Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study. Clinical Therapeutics. 29:2055-2067. 2007
- Bisphosphonates for the Treatment of Postmenopausal Osteoporosis: An Update. Clinical & Translational Metabolism. 5:145-152. 2007
- Introduction. Clinical & Translational Metabolism. 5:129-129. 2007
- Calcium supplementation on bone loss in postmenopausal women. Clinical Respiratory Journal. 2010:CD004526. 2007
- Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database of Systematic Reviews. CD003376. 2007
- Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database of Systematic Reviews. CD004523. 2007
- Extremity magnetic resonance imaging.. Journal of Rheumatology. 34:1634-1635. 2007
- Age and drug therapy are key prognostic factors for first clinical fracture in patients with primary osteoporosis. Osteoporosis International. 18:1091-1100. 2007
- Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care? The case of Ontario, Canada. Osteoporosis International. 18:819-827. 2007
- Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporosis International. 18:711-719. 2007
- Prevalence of knee abnormalities in patients with osteoarthritis and anterior cruciate ligament injury identified with peripheral magnetic resonance imaging: a pilot study.. Canadian Association of Radiologists Journal. 58:167-175. 2007
- The Use of Hip Protectors in Long-Term Care Facilities: A Survey of Nursing Home Staff. Journal of the American Medical Directors Association. 8:229-232. 2007
- Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis. Journal of Clinical Epidemiology. 60:336-344. 2007
- Therapeutic advances in the treatment of osteoporosis. Expert Opinion on Therapeutic Patents. 17:277-285. 2007
- Changes to Osteoporosis Prevalence According to Method of Risk Assessment. Journal of Bone and Mineral Research. 22:228-234. 2007
- Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture. JAMA Internal Medicine. 167:188-188. 2007
- Accuracy and test–retest precision of quantitative cartilage morphology on a 1.0T peripheral magnetic resonance imaging system. Osteoarthritis and Cartilage. 15:110-115. 2007
- Biochemical Measurement of Muscle Injury Created by Lumbar Surgery. Clinical and Investigative Medicine. 30:12-12. 2007
- Diagnosis and treatment of Paget’s disease of bone. Clinical and Investigative Medicine. 30:210-210. 2007
- Oral Corticosteroids in Asthma: A Review of Benefits and Risks. Canadian Respiratory Journal. 14:1c-7c. 2007
- Osteoporose-Update. Osteologie. 16:53-59. 2007
- Osteoporosis Knowledge and Information Needs in Healthcare Professionals Caring for Patients With Fragility Fractures. Orthopaedic Nursing. 26:27???35-27???35. 2007
- Patient Adherence to Osteoporosis Medications. Drugs and Aging. 24:37-55. 2007
- Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.. Clinical interventions in aging. 2:275-282. 2007
- Strontium ranelate for preventing and treating postmenopausal osteoporosis. Clinical Respiratory Journal. 2006:CD005326. 2006
- What is the Number of Older Canadians Needed to Screen by Measurement of Bone Density to Detect an Undiagnosed Case of Osteoporosis? A Population-Based Study From CaMos. Journal of Clinical Densitometry. 9:413-418. 2006
- Bone Strength: The Whole Is Greater Than the Sum of Its Parts. Seminars in Arthritis and Rheumatism. 36:22-31. 2006
- The Effects of Antifracture Therapies on the Components of Bone Strength: Assessment of Fracture Risk Today and in the Future. Seminars in Arthritis and Rheumatism. 36:10-21. 2006
- Treating osteoporosis: economic aspects of bisphosphonate therapy. Expert Opinion on Pharmacotherapy. 7:1457-1467. 2006
- Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database of Systematic Reviews. 2021:CD005326. 2006
- Parathyroid hormone for the treatment of osteoporosis: a systematic review. CANADIAN MEDICAL ASSOCIATION JOURNAL. 175:52-59. 2006
- Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Current Medical Research and Opinion. 22:1425-1436. 2006
- Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon. Seminars in Arthritis and Rheumatism. 35:293-305. 2006
- The Natural Progression of Health-Related Quality of Life: Results of a Five-Year Prospective Study of SF-36 Scores in a Normative Population. Quality of Life Research. 15:527-536. 2006
- A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis. Osteoporosis International. 17:379-386. 2006
- Determinants of health-related quality of life in women with vertebral fractures. Osteoporosis International. 17:355-363. 2006
- Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study. Osteoporosis International. 17:217-224. 2006
- Glucocorticoid-Induced Osteoporosis. Women's Health. 2:65-74. 2006
- Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease. Drug Safety. 29:1133-1152. 2006
- Case report: osteogenesis imperfecta Elusive cause of fractures.. Canadian Family Physician. 51:1655-1657. 2005
- Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporosis International. 16:1461-1474. 2005
- Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskeletal Disorders. 6:39. 2005
- Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskeletal Disorders. 6:47. 2005
- Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporosis International. 16:1836-1840. 2005
- In whom and how to prevent glucocorticoid-induced osteoporosis. Best Practice and Research in Clinical Rheumatology. 19:1039-1064. 2005
- The relationships between bone mineral density in the spine, hip, distal femur and proximal tibia and medial minimum joint space width in the knees of healthy females. Osteoarthritis and Cartilage. 13:872-878. 2005
- Alendronate reduced clinical and radiographic vertebral fractures in postmenopausal women with osteopenia. ACP journal club. 143:46-46. 2005
- Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment. Journal of Clinical Densitometry. 8:273-277. 2005
- Are Oral Bisphosphonates Effective in Improving Lumbar Bone Mineral Density in Breast Cancer Survivors With Osteopenia or Osteoporosis?. Journal of Obstetrics and Gynaecology Canada. 27:759-764. 2005
- Measurement of cervical flexor endurance following whiplash. Disability and Rehabilitation. 27:801-807. 2005
- Osteoporosis: Preventing the deterioration of bone. Geriatrics and Aging. 8:60-66. 2005
- Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong?. Journal of Bone and Mineral Research. 20:898-905. 2005
- Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporosis International. 16:568-578. 2005
- Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporosis International. 16:403-410. 2005
- In Response. Journal of Obstetrics and Gynaecology Canada. 27:322-322. 2005
- Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data. Aging - Clinical and Experimental Research. 17:150-156. 2005
- A Systematic Review of the Effect of Alendronate on Bone Mineral Density in Men. Journal of Clinical Densitometry. 8:7-13. 2005
- Abnormalities identified in the knees of asymptomatic volunteers using peripheral magnetic resonance imaging. Osteoarthritis and Cartilage. 13:181-186. 2005
- Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. Osteoporosis International. 16:208-215. 2005
- Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis. Drug Safety. 28:721-730. 2005
- Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene. Journal of the National Cancer Institute. 96:1751-1761. 2004
- Prediction of falls using a risk assessment tool in the acute care setting. BMC Medicine. 2:1. 2004
- The osteoporosis care gap in Canada. BMC Musculoskeletal Disorders. 5:11. 2004
- Attitudes of Women Who are Currently Using or Recently Stopped Estrogen Replacement Therapy With or Without Progestins: Results of the Aware Survey. Journal of Obstetrics and Gynaecology Canada. 26:967-973. 2004
- Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?. Journal of Rheumatology. 31:1993-1995. 2004
- Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate. Journal of Clinical Densitometry. 7:255-261. 2004
- Stability of Normative Data for the SF-36. Canadian Journal of Public Health. 95:387-391. 2004
- [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].. MMW Fortschritte der Medizin. 146:53. 2004
- Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. Current Medical Research and Opinion. 20:1161-1163. 2004
- The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. Current Medical Research and Opinion. 20:903-910. 2004
- A Comparison of the Effects of Raloxifene and Conjugated Equine Estrogen on Bone and Lipids in Healthy Postmenopausal Women. JAMA Internal Medicine. 164:871-871. 2004
- Efficacy of risedronate on clinical vertebral fractures within six months. Current Medical Research and Opinion. 20:433-439. 2004
- The treatment of glucocorticoid-induced osteoporosis. Journal of Steroid Biochemistry and Molecular Biology. 88:337-349. 2004
- Rational use of oral bisphosphonates for the treatment of osteoporosis. Current Osteoporosis Reports. 2:17-23. 2004
- Risedronat zur Prävention und Therapie der postmenopausalen Osteoporose. Praxis. 93:330-330. 2004
- Calcium supplementation on bone loss in postmenopausal women. Cochrane Database of Systematic Reviews. CD004526. 2004
- Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment. Clinical Therapeutics. 26:15-28. 2004
- The Impact of Fragility Fracture on Health-Related Quality of Life. Drugs and Aging. 21:711-730. 2004
- A 6-Mo Home-Based Exercise Program May Slow Vertebral Height Loss. Journal of Clinical Densitometry. 6:391-400. 2003
- Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study. BMC Musculoskeletal Disorders. 4:13. 2003
- What Predicts Early Fracture or Bone Loss on Bisphosphonate Therapy?. Journal of Clinical Densitometry. 6:315-322. 2003
- Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporosis International. 14:913-917. 2003
- The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporosis International. 14:895-904. 2003
- Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database. Osteoporosis International. 14:808-813. 2003
- Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition. Canadian Journal of Physiology and Pharmacology. 81:952-958. 2003
- Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone. 33:522-532. 2003
- Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporosis International. 14:677-682. 2003
- Incidence of Nonvertebral Fractures in Relation to Time on Treatment and Bone Density in Glucocorticoid-Treated Patients. Journal of Clinical Rheumatology. 9:170-175. 2003
- In Vivo Measurement of Apparent Trabecular Bone Structure of the Radius in Women With Low Bone Density Discriminates Patients with Recent Wrist Fracture from Those Without Fracture. Journal of Clinical Densitometry. 6:35-43. 2003
- Kyphoplasty and vertebroplasty for the treatment of osteoporotic vertebral compression fractures. Geriatrics and Aging. 6:47-52. 2003
- Prevention and treatment of corticosteroid-induced osteoporosis in the elderly. Annals of Long-Term Care. 11:42-48. 2003
- Risedronate for the prevention and treatment of postmenopausal osteoporosis.. Cochrane Database of Systematic Reviews. CD004523. 2003
- The Impact of Sampling and Measurement on the Prevalence of Self‐Reported Pain in Canada. Pain Research and Management. 8:157-163. 2003
- Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. BMC Musculoskeletal Disorders. 3:6. 2002
- The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database For Osteoporosis and Osteopenia (CANDOO). BMC Musculoskeletal Disorders. 3:22. 2002
- The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskeletal Disorders. 3:11. 2002
- Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study. Osteoporosis International. 13:907-913. 2002
- Diagnosis and management of vertebral fractures in elderly adults. American Journal of Medicine. 113:220-228. 2002
- Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial. Journal of Clinical Endocrinology and Metabolism (JCEM). 87:3609-3617. 2002
- Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial. Journal of Clinical Endocrinology and Metabolism (JCEM). 87:3609-3617. 2002
- II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women. Endocrine Reviews. 23:508-516. 2002
- III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis. Endocrine Reviews. 23:517-523. 2002
- IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis. Endocrine Reviews. 23:524-528. 2002
- Meta-Analyses of Therapies for Postmenopausal Osteoporosis. Endocrine Reviews. 23:496-497. 2002
- The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis. Calcified Tissue International. 71:103-111. 2002
- V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women. Endocrine Reviews. 23:529-539. 2002
- VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis. Endocrine Reviews. 23:540-551. 2002
- VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis. Endocrine Reviews. 23:552-559. 2002
- VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women. Endocrine Reviews. 23:560-569. 2002
- Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Education and Counseling. 47:245-255. 2002
- Cockcroft-Gault equation and estimation of creatinine clearance: The Reply. American Journal of Medicine. 112:684-685. 2002
- Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis. JAMA Internal Medicine. 162:1140-1140. 2002
- Is There Regional Variation in the SF-36 Scores of Canadian Adults?. Canadian Journal of Public Health. 93:233-237. 2002
- Anticonvulsant drug use and low bone mass in adults with neurodevelopmental disorders. QJM - Monthly Journal of the Association of Physicians. 95:219-223. 2002
- North American Male Reference Population for Speed of Sound in Bone at Multiple Skeletal Sites. Journal of Clinical Densitometry. 5:63-71. 2002
- Corticosteroid-Induced Osteoporosis. Treatments in Endocrinology. 1:271-279. 2002
- Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis. Drug Safety. 25:781-790. 2002
- Effect of altered physical loading on bone and muscle in the forearm. Canadian Journal of Physiology and Pharmacology. 79:1015-1022. 2001
- Positive Effect of Etidronate Therapy Is Maintained After Drug Is Terminated in Patients Using Corticosteroids. Journal of Clinical Densitometry. 4:363-371. 2001
- Estimation of creatinine clearance in elderly persons in long-term care facilities. American Journal of Medicine. 111:569-573. 2001
- The Influence of Osteoporotic Fractures on Health-Related Quality of Life in Community-Dwelling Men and Women across Canada. Osteoporosis International. 12:903-908. 2001
- Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:1023-1029. 2001
- Oval contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:1023-1029. 2001
- Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions. Osteoporosis International. 12:849-857. 2001
- Lengthy Hospitalization Associated with Vertebral Fractures Despite Control for Comorbid Conditions. Osteoporosis International. 12:870-874. 2001
- QUALITY OF LIFE IN OSTEOPOROSIS. Nursing Clinics of North America. 36:481-489. 2001
- Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis. Best Practice and Research in Clinical Rheumatology. 15:469-481. 2001
- Economic Implications of Hip Fracture: Health Service Use, Institutional Care and Cost in Canada. Osteoporosis International. 12:271-278. 2001
- A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis. Osteoporosis International. 12:140-151. 2001
- Corticosteroid-Induced Osteoporosis. Drug Safety. 24:607-624. 2001
- Corticosteroid-induced osteoporosis.. International Journal of Fertility and Women's Medicine. 46:190-205. 2001
- Effect of altered physical loading on bone and muscle in the forearm. Canadian Journal of Physiology and Pharmacology. 79:1015-1022. 2001
- Etidronate for treating and preventing postmenopausal osteoporosis. Clinical Respiratory Journal. CD003376. 2001
- Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial. Arthritis and Rheumatism. 44:202-211. 2001
- Risedronate prevented new vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Evidence-based Obstetrics and Gynecology. 2:106-107. 2000
- Steroid-induced osteoporosis. International Journal of Fertility and Menopausal Studies. 45:373. 2000
- A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.. Journal of Rheumatology. 27:2424-2431. 2000
- Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis. Osteoporosis International. 11:727-738. 2000
- Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. Clinical and Experimental Rheumatology. 18:S79-S86. 2000
- The Canadian Score™ Questionnaire. Journal of Clinical Densitometry. 3:269-280. 2000
- Alendronate for the Treatment of Osteoporosis in Men. New England Journal of Medicine. 343:604-610. 2000
- Canadian normative data for the SF-36 health survey. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:265-271. 2000
- Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:265-271. 2000
- Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis. Bone. 27:311-318. 2000
- Predicting Subsequent Bone Density Response to Intermittent Cyclical Therapy with Etidronate from Initial Density Response in Patients with Osteoporosis. Osteoporosis International. 11:607-614. 2000
- Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Praxis. 89:1067-1069. 2000
- A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.. Journal of Rheumatology. 27:1506-1512. 2000
- Etidronate Therapy in the Treatment and Prevention of Osteoporosis. Journal of Clinical Densitometry. 3:79-95. 2000
- Glucocorticoid-induced osteoporosis. Drug Development Research. 49:120-134. 2000
- Glucocorticoid‐induced osteoporosis. Drug Development Research. 49:120-134. 2000
- Glucocorticoid-induced osteoporosis. Current Rheumatology Reports. 2:53-61. 2000
- Management of corticosteroid-induced osteoporosis. Seminars in Arthritis and Rheumatism. 29:228-251. 2000
- Bisphosphonates for steroid induced osteoporosis. Cochrane Database of Systematic Reviews. CD001347. 2000
- Calcitonin for preventing and treating corticosteroid-induced osteoporosis. Clinical Respiratory Journal. 2010:CD001983. 2000
- Etridronate therapy in the treatment and prevention of osteoporosis.. Journal of Clinical Densitometry. 3:79-95. 2000
- Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. Clinical and Experimental Rheumatology. 18. 2000
- Seropositive symmetrical inflammatory polyarthritis appearing after treatment with fludarabine in a patient with non-hodgkin's lymphoma. Blood. 96. 2000
- In Vivo Detection of Structural Differences Between Dominant and Nondominant Radii Using Peripheral Quantitative Computed Tomography. Journal of Clinical Densitometry. 2:413-422. 1999
- Development and Validation of the Mini-Osteoporosis Quality of Life Questionnaire (OQLQ) in Osteoporotic Women with Back Pain due to Vertebral Fractures. Osteoporosis Quality of Life Study Group. Osteoporosis International. 10:207-213. 1999
- Corticosteroid-induced osteoporosis. Part II: Prevention and treatment. Mature Medicine Canada. 2:133-137. 1999
- 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.. Journal of Rheumatology. 26:1545-1549. 1999
- Corticosteroid-induced osteoporosis part I: Pathophysiology, clinical features and assessment. Mature Medicine Canada. 2:77-81. 1999
- Gender Differences in Normal Age-Dependent Patterns of Radial Bone Structure and Density. Journal of Clinical Densitometry. 2:163-173. 1999
- A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.. Journal of Rheumatology. 26:1148-1157. 1999
- Are bisphosphonates useful in the management of corticosteroid induced osteoporosis in transplant patients?. Journal of Nephrology. 12:5-8. 1999
- Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis. Climacteric. 2:237-237. 1999
- Responsiveness of endpoints in osteoporosis clinical trials--an update.. Journal of Rheumatology. 26:222-228. 1999
- Women's decisions about hormone replacement therapy after education and bone densitometry.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 159:1253-1257. 1998
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. New England Journal of Medicine. 339:292-299. 1998
- Intermittent therapy with etidronate and calcium helps prevent osteoporosis secondary to steroids. Clinical and Experimental Rheumatology. 16:117-118. 1998
- Research data on alendronate: biased opinions?. Canadian Family Physician. 44:971-976. 1998
- Research data on alendronate: biased opinions? Response. Canadian Family Physician. 44:974-+. 1998
- The pyramids of rheumatoid arthritis - Reply. Journal of Rheumatology. 25:819-819. 1998
- Back to the future: The pyramids of rheumatoid arthritis - reply. Journal of Rheumatology. 25:602-602. 1998
- Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.. Canadian Family Physician. 44:327-332. 1998
- Corticosteroid-induced osteoporosis.. Journal of the American Medical Women's Association. 53:25-40. 1998
- Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis. PharmacoEconomics (Auckland). 14:559-573. 1998
- Cyclical etidronate therapy in the prevention and treatment of corticosteroid-induced osteoporosis. Reviews in Contemporary Pharmacotherapy. 9:267-275. 1998
- Intermittent Etidronate and Corticosteroid-Induced Osteoporosis. New England Journal of Medicine. 337:1921-1921. 1997
- Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.. Journal of Rheumatology. 24:2308-2313. 1997
- Measuring Quality of Life in Women with Osteoporosis. Osteoporosis International. 7:478-487. 1997
- Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis. New England Journal of Medicine. 337:382-388. 1997
- Back to the future: the pyramids of rheumatoid arthritis.. Journal of Rheumatology. 24:1023-1027. 1997
- Guidelines for osteoporosis trials.. Journal of Rheumatology. 24:1234-1236. 1997
- Osteoporosis clinical trials endpoints: candidate variables and clinimetric properties.. Journal of Rheumatology. 24:1222-1229. 1997
- A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid Hormone Versus Cyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis. Journal of Clinical Endocrinology and Metabolism (JCEM). 82:620-628. 1997
- A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid HormoneVersusCyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis¹. Journal of Clinical Endocrinology and Metabolism (JCEM). 82:620-628. 1997
- Prevention of corticosteroid induced osteoporosis.. Journal of Rheumatology. 24:407. 1997
- Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis. Rheumatology. 36:255-259. 1997
- A Model for Osteoporosis Education of Students and Health Professionals. Therapeutic Innovation and Regulatory Science. 31:287-291. 1997
- Corticosteroid-Induced Osteoporosis. American Journal of the Medical Sciences. 313:41-49. 1997
- Clinical practice guidelines for the diagnosis and management of osteoporosis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 155:1113-1133. 1996
- Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 155:945-948. 1996
- Current treatment options for osteoporosis.. The Journal of rheumatology. Supplement. 45:11-14. 1996
- Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.. Journal of Rheumatology. 23:995-1000. 1996
- Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up. Scandinavian Journal of Rheumatology. 25:91-93. 1996
- Osteoporosis - Its diagnosis, management and treatment with a new oral bisphosphonate agent, etidronate. Today's Therapeutic Trends. 14:13-24. 1996
- Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.. Journal of Rheumatology. 21:1922-1926. 1994
- Interrater reliability of the tender point criterion for fibromyalgia.. Journal of Rheumatology. 21:370-371. 1994
- Corticosteroid-induced osteoporosis. Seminars in Arthritis and Rheumatism. 22:375-384. 1993
- Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis and Rheumatism. 36:750-756. 1993
- An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.. Journal of Clinical Investigation. 91:1138-1148. 1993
- Interrater reliability of the tender point criterion for fibromyalgia.. Journal of Rheumatology. 19:1955-1959. 1992
- Markers of bone turnover in rheumatoid arthritis.. Journal of Rheumatology. 18:1119-1120. 1991
- Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials.. Journal of Rheumatology. 18:447-451. 1991
- Remodelling the pyramid: the therapeutic target of rheumatoid arthritis.. Journal of Rheumatology. 17:987-989. 1990
- Bone densitometry.. Journal of Rheumatology. 17:419-420. 1990
- Preventing postmenopausal osteoporosis.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 139:826-827. 1988
- A clinician's guide for conducting randomized trials in individual patients.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 139:497-503. 1988
- Late onset gold induced thrombocytopenia.. Journal of Rheumatology. 15:1450-1451. 1988
- HLA-DQ BETA-CHAIN POLYMORPHISM IN HLA-DR4 HAPLOTYPES ASSOCIATED WITH RHEUMATOID ARTHRITIS. The Lancet. 330:1118-1120. 1987
- Gold induced thrombocytopenia: 12 cases and a review of the literature. Seminars in Arthritis and Rheumatism. 16:287-293. 1987
- HLA TYPING, PLATELET ASSOCIATED IMMUNOGLOBULINS AND ANTICARDIOLIPIN ANTIBODY - REPLY. Journal of Rheumatology. 13:989-990. 1986
- GOLD INDUCED THROMBOCYTOPENIA - REPLY. Journal of Rheumatology. 13:227-227. 1986
- Gold induced aplastic anemia.. Journal of Rheumatology. 12:1011-1012. 1985
- Gold induced thrombocytopenia: platelet associated IgG and HLA typing in three patients.. Journal of Rheumatology. 11:355-357. 1984
- Bio-inorganic effects of D-penicillamine in children and in the elderly.. Clinical and Investigative Medicine. 7:77-83. 1984
- Raloxifene use in clinical practice: efficacy and safety. Menopause. 16:413-421.